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I 
  
Abstract 
Intoxication-type inborn errors of metabolism (IT-IEM) are a group of rare genetic dis-
eases that include urea cycle disorders and organic acidurias. Affected patients depend on a 
strict nutritional diet and are at risk of severe metabolic crises. Impact of the disease on eve-
ryday life remains crucial and can be measured by health-related quality of life (HrQoL). 
This dissertation project sought to develop and psychometrically evaluate the first disease-
specific HrQoL questionnaire for paediatric IT-IEM patients.  
A systematic literature review laid the foundation of the project, summarizing previous 
research on HrQoL in IT-IEM patients. With the goal of identifying core topics relating to 
HrQoL in the affected population, patients and parents were then invited to focus group in-
terviews. Systematic content analysis allowed to identify 14 categories within the three pri-
mary dimensions of physical, mental, and social HrQoL. Based on these categories, a set of 
questions — both for self-rating (patients) and proxy-rating (parent) — were constructed for 
patients from 4 to 7 years (2 to 7 for proxy rating) and from 8 to 18 years. This thesis psy-
chometrically evaluated the versions for patients from 8 to 18 years.  
Carefully developed in accordance with established guidelines, the new questionnaire 
MetabQoL 1.0 appears to be a promising step towards measuring the subjective impact of 
IT-IEM among patients, both in research and clinical practice. 
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Zusammenfassung 
Stoffwechselkrankheiten vom Vergiftungstyp (Englisch: IT-IEM) sind eine Gruppe 
seltener, angeborener Krankheiten wie Harnstoffzyklusstörungen und Organoazidurien. Pa-
tienten sind auf eine strikte Diät angewiesen und leben mit dem Risiko schwerwiegender 
Stoffwechselkrisen. Die Krankheit belastet den Alltag der Patienten, was mit dem Konstrukt 
der gesundheitsbezogenen Lebensqualität (Englisch: HrQoL) gemessen werden kann. Dieses 
Dissertationsprojekt hatte zum Ziel den ersten krankheitsspezifischen Fragebogen zu HrQoL 
bei IT-IEM Patienten zu entwickeln und psychometrisch zu evaluieren.  
Zu Beginn wurde in einer systematischen Übersichtsarbeit bisherige Forschung zu 
HrQoL bei IT-IEM analysiert. Um zentrale Themen bezüglich HrQoL für Betroffene zu iden-
tifizieren, wurden Patienten und Eltern zu Fokusgruppeninterviews eingeladen. Mithilfe sys-
tematischer Inhaltsanalyse der Interviews, wurden 14 Kategorien in den drei 
Hauptdimensionen der physischen, mentalen und der sozialen HrQoL benannt. Darauf basie-
rend wurden Fragen zur HrQoL entwickelt, jeweils für Patienten im Alter von 4 bis 7 Jahren 
(2 bis 7 bei Fremdauskunft) und 8 bis 18 Jahren. Alle Fragen wurden sowohl für Selbstaus-
kunft (Patient) als auch für Fremdauskunft (Eltern) bereitgestellt. 
Sorgfältig und anhand etablierter Richtlinien entwickelt, ist der neue Fragebogen Me-
tabQoL 1.0 ein vielversprechender Schritt zur Erfassung der subjektiven Belastung von IT-
IEM auf Patienten in Forschung und klinischer Praxis. 
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1. Intoxication-type inborn errors of metabolism 
Intoxication-type inborn errors of metabolism (IT-IEM) are a group of rare metabolic 
diseases that include urea cycle disorders (UCD), organic acidurias (OA), maple syrup urine 
disease (MSUD) and tyrosinemia type 1 (TYR 1). Incidence rates are currently estimated to 
be approximately 1:35’000 for UCD (Marshall L Summar et al., 2013), 1:21’000 for OA 
(Dionisi-Vici et al., 2002), 1:185’000 for MSUD (Chuang & Shih, 2001), and 1:100’000 for 
TYR 1 (De Laet et al., 2013), but all of these are probably underestimates, due to the under-
diagnosis of fatal or atypical cases (Häberle et al., 2012).  
Most IT-IEM are transmitted genetically following an autosomal-recessive inheritance 
pattern (Nassogne, Héron, Touati, Rabier, & Saudubray, 2005). The autosomal recessive pat-
tern generally implies that both of a patient’s parents are genetic carriers of the disease, but 
completely healthy because they have one intact gene. In this case, there is a 25% risk for 
each pregnancy that a child of these parents will be affected. Due to this inheritance pattern, 
IT-IEM are more prevalent in families with a history of consanguinity. Furthermore, the in-
cidence may be specifically high in certain populations due to founder effects. This is the 
case for MSUD in the Old Order Mennonite community, in which it has an estimated inci-
dence of approximately 1:150 (Love-Gregory, Dyer, Grasela, Hillman, & Phillips, 2001).  
As an exception, the most common UCD, OTC-deficiency (see Figure 2), is transmitted 
via an X-linked recessive inheritance pattern (Nassogne et al., 2005). Females carrying the 
diseases on one of their two X chromosomes may have any degree of disease severity, de-
pending on skewed X-inactivation. Many females are mildly affected and may exhibit atyp-
ical symptoms, so that the diagnosis may be missed. Males, who by definition only carry the 
one affected X chromosome, generally are more severely affected and present with symptoms 
earlier in life. 
Biochemically, the genetic defect results in the malfunction or dysfunction of a given 
enzyme (or, in one instance, a transport protein). Enzymes  serve as biological catalysts and 
ease the transformation of one substance into another. If the enzyme is dysfunctional, the 
substrates cannot be metabolized properly and accumulate, while the product remains either 
missing or diminished for use in later metabolic steps. Metabolic pathways with functional 
versus dysfunctional enzymes are schematically depicted in Figure 1, including the resulting 
problems with dysfunctional enzymes and corresponding therapeutic approaches. In UCD, 
there is a perturbance in the metabolism of ammonia, a product of protein catabolism. Other 
IT-IEM involve other pathways of amino acid catabolism. Amino acids are the building 
blocks of protein. An overview of metabolic pathways relevant for each IT-IEM, including 
the site of the defect, is depicted in Figures 3 and 4 (Ruzkova et al., 2015; Zschocke & 
Hoffmann, 2012).  
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Figure 1: Basic function of enzymes in healthy persons versus IT-IEM patients 
 
In patients with complete enzyme deficiencies, symptoms typically present in the 
neonatal period, characterized by acute deterioration in the infant’s clinical condition. One 
major problem is the accumulation of toxic substances that cannot be metabolized properly 
(Figure 1: Substance A), such as ammonia in UCD. This so-called metabolic crisis may lead 
to coma, death or severe sequelae if left untreated (Baumgartner et al., 2014; Häberle et al., 
2012). In patients with partial enzyme deficiencies, the disease may become manifest at any 
age and include a wide range of  less-specific symptoms like neurodevelopmental delay, 
failure to thrive, or psychiatric symptoms like hallucinations or personality change 
(Baumgartner et al., 2014; Häberle et al., 2012). Metabolic crises can occur in all patients at 
any age, often triggered by febrile infections, vomiting, fasting, excessive protein load, 
psychological stress, or intense physical excersise (Häberle et al., 2012). Crises often cause 
brain damage in survivors, resulting in neurological symptoms like movement or 
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developmental deficits. In the long term, some IT-IEM can have specific organ sequelae; for 
example, kidney disease or cardiomyopathy in some OA (Baumgartner et al., 2014).  
 
 
Figure 2: Biochemical localisation of urea cycle disorders in the urea cycle pathway 
The urea cycle transforms the toxic substance ammonia into urea. All urea cycle disorders result in the accumu-
lation of ammonia. As an exception, HHH syndrome / ORNT1 deficiency is not manifest as an enzyme defect, 
but as a transporter defect. The content of this figure was adapted and simplified from Zschocke and Hoffmann 
(2012). 
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Figure 3: Biochemical localisation of organic acidurias, maple syrup urine disease, and tyrosinemia type 1 in 
different metabolic pathways 
These diseases all affect amino acid (leucine, isoleucine, valine, lysine, tryptophan, phenylalanine) degradation. 
The content of this figure was adapted and simplified from Ruzkova (2015) and Zschocke and Hoffmann (2012).  
 
Due to their sometimes non-specific presentation and rarity, IT-IEM are often not recognized 
early enough to prevent death or severe brain damage, even if relatively effective therapies 
are available (Baumgartner et al., 2014). For some diseases, the pathophysiological 
mechanisms are incompletely understood and current treatment practice may be insufficient 
to prevent severe impairment. Thus, outcomes remain poor for many IT-IEM . 
Short-term (emergent) and long-term treatment must be distinguished. Short-term treatment 
aims to stabilize an acutely ill patient by, for example, having them cease all protein intake 
and start specific drug treatment and potentially undergo extracoporeal detoxification by 
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means of dialysis (Baumgartner et al., 2014). Long-term treatment generally includes a low-
protein diet, since some protein or specific amino acid cannot be metabolized properly. This 
being said, protein in general and essential amino acids in particular are required for growth 
and development. Therefore, patients must be supplied with synthetic amino acid mixtures 
in the form of drinks or powders. These mixtures need to be taken daily, ideally divided into 
2-3 doses in order to provide sufficient total protein. Additionally, medication can be 
prescribed to increase the excretion of toxic substances (Häberle et al., 2012). Feeding 
problems are common in patients with IT-IEM, which is why tube feeding may be necessary 
in certain cases (Baumgartner et al., 2014). Usually, this entails a gastric feeding tube, which 
allows to administer medication and nutritional supplements to maintain satisfactory 
nutritional status and metabolic stability (Baumgartner et al., 2014). In selected patients with 
a UCD, liver transplantation can be an option (Leonard & McKiernan, 2004). Treatments 
like gene therapy, enzyme replacement, and liver cell transplantation are currently at different 
stages of development, but not yet routinely offered to IT-IEM patients (Baumgartner et al., 
2014; Häberle et al., 2012).  
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2.  Health-related quality of life 
2.1. Definition 
The term Quality of Life (QoL) was first used in social sciences in the seventies 
(Bullinger, 2014). At this time, medicine was evolving rapidly in many industrial countries, 
resulting in major improvements in both diagnostics and treatment. This led to an increase in 
the number of patients surviving with a wide range of chronic diseases (Landolt & 
Sennhauser, 2007). Consequently, survival ceased to be the only indicator of a positive treat-
ment outcome, so that a broader concept of health, described by the World Health Organisa-
tion (WHO) in 1948, gained importance. The WHO defined health as a state of complete 
physical, mental and social well-being, as opposed to being merely the absence of disease 
(World Health Organisation, 1948).  
Today, the WHO definition for health is often cited as the basis of research on health-
related quality of life (HrQoL). HrQoL must be distinguished from the broader term QoL, 
which not only encapsulates health-related themes, but also issues like political freedom and 
material security (Bullinger, 2009). Of the many existing definitions of HrQoL, most agree 
that HrQoL is subjective and multidimensional. There is consensus that physical, mental, and 
social functioning are its three core dimensions (Landolt & Sennhauser, 2007; Rajmil et al., 
2004). Focusing on young people with chronic illness, the dynamic character of HrQoL, 
which changes over time, is important to note (Taylor, Gibson, & Franck, 2008). As such, 
HrQoL of a child with a chronic condition could decline because the underlying medical 
condition worsens, but also because the patient’s circumstances change (e.g., transition to a 
new school adding novel challenges), or because of the patient’s self-evaluation of the situa-
tion (e.g., adolescents comparing themselves to peers). Equally, such mechanisms might aug-
ment HrQoL. Throughout this present thesis, the definition of HrQoL proposed by Varni, 
Seid, and Rode (1999) will be used, since its focus is on disease and treatment and matches 
the examined population. HrQoL is thereby explained as “a patient’s perception of the impact 
of disease and treatment on functioning in a variety of dimensions including physical, psy-
chological and social domains” (Varni et al., 1999, p.126). This definition is depicted with 
examples in Figure 4. Importantly, the term domain is often referred to as a dimension or 
scale in questionnaire development; as such, these terms are used interchangeably throughout 
the following sections of this thesis. 
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,  
Figure 4: Health-related quality of life  
Based on the definition of Varni et al. (1999)  
 
2.2. Considerations regarding HrQoL measurement 
Different considerations must be taken into account when developing, applying, and 
evaluating HrQoL measurements. Thus, decisions about (1) the informant (patient or proxy), 
(2) the modality of assessment, (3) the instrument’s specificity, and (4) age-related issues 
need to be made.  
 
Informant: self- versus proxy-assessments 
When HrQoL research first started to be conducted in paediatric populations, patients’ 
HrQoL was predominantly rated by medical staff (Landolt & Sennhauser, 2007). However, 
given that HrQoL is generally deemed a subjective construct, the view emerged that HrQoL 
might be rated differently and more accurately from a patient perspective.  
Since HrQoL is a construct that reflects the subjective view of an individual, self-re-
porting is the method of choice when choosing the informant (Matza et al., 2013). In some 
situations (e.g., when patients are very young or cannot answer the questionnaire due to some 
impairment), supplementation with proxy ratings (by parents or medical staff) is the best 
alternative. Furthermore, proxy-ratings can be very valuable to use in addition to self-ratings 
to gain insights from multiple perspectives (Eiser & Jenney, 2007). However, one must be 
aware that only poor to moderate correlations have been identified between self- and proxy-
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assessments, and that good agreement has been shown mostly for more observable facets like 
physical symptoms. Other measures from the mental dimension, like cognition or emotions, 
do not correlate well (Eiser & Jenney, 2007). In general, agreement is better in sick than in 
healthy children (Eiser & Jenney, 2007). Interestingly, sick children usually rate their HrQoL 
better than their parents do, while proxy-ratings by parents tend to be higher than self-ratings 
in healthy children (Upton, Lawford, & Eiser, 2008). In summary, a multiple-informant per-
spective is preferred, whenever possible, since proxy-ratings are a very important additional 
source of information, but not interchangeable with self-ratings.  
 
Modality 
One can assess HrQoL by letting individuals complete a questionnaire by themselves 
(with paper and a pencil or on an electronic device) or during an interview (Gerharz, Ravens-
Sieberer, & Eiser, 2008). Self-completion is a very efficient method; however, it needs to be 
used cautiously in the paediatric population since written questionnaires lack certain benefits 
of in-person interviews, like the provision of additional guidance to the respondent, thereby 
increasing the comprehensibility and feasibility of the questionnaire, both which are essential 
characteristics of effective psychological testing. As a trade-off, the greater impact of social 
desirability bias while answering questions, as well as other potential interviewer effects must 
be taken into account with face-to-face interviews (R. E. Davis, Couper, Janz, Caldwell, & 
Resnicow, 2010). For example, children may want to be perceived as particularly brave when 
they report their symptoms or popular when they report on social inclusion or exclusion.  
 
Instrument specificity 
Depending on the goal of the assessment, either generic or disease-specific assessment 
tools must be chosen. Generic instruments like the KIDSCREEN (The KIDSCREEN Group 
Europe, 2006) and the PedsQL (Varni et al., 1999) questionnaires are designed to assess 
HrQoL in all populations, both healthy and diseased. One advantage to such instruments is 
that they allow for HrQoL to be compared between different groups. However, these instru-
ments lack sensitivity for certain disease-specific HrQoL issues, like diet in diabetic patients. 
Disease-specific instruments like the PKU-QOL (Regnault et al., 2015) fill this gap, having 
been designed for use with one disease or a few closely-related diseases in mind in an attempt 
to assess HrQoL specifically in this population. Thus, these instruments have shown high 
responsiveness to changes of HrQoL (S. Wiebe, Guyatt, Weaver, Matijevic, & Sidwell, 
2003). The downside is that these tools are of limited use when employed to compare dis-
eased versus healthy populations, or groups with different clinically dissimilar diseases.  
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The modular approach elegantly combines the advantages of generic and disease-spe-
cific tools. A basic generic questionnaire can thereby be extended by adding disease-specific 
tools. One example of the modular approach is the DISABKIDS (The DISABKIDS Group 
Europe, 2006) questionnaire, which uses a chronic-generic basic tool for all patients with a 
chronic disease, but can then be extended by means of short, disease-specific modules.  
 
Age-related issues in the paediatric population 
HrQoL research started later in children than in adults, due to various sources of scep-
ticism towards the applicability of any construct as complex as HrQoL in children (De Civita 
et al., 2005). Over the last several years, however, several new HrQoL measures have 
emerged for use in children and adolescents (Solans et al., 2008). Still, several reasons remain 
as to why HrQoL assessment instruments for the paediatric population deserve special atten-
tion (Landolt & Sennhauser, 2007).  
First, children have a different understanding of health and disease than adults. Their 
understanding and beliefs might not be congruent with those that adults have, which hampers 
comparisons (Bullinger, 2014). Second, areas that define their HrQoL might be specific to 
children’s stage of development. The relevance of school and relationships with peers are 
examples that are especially important within the paediatric population, even varying in im-
portance between childhood and adolescence. This again emphasizes the need to define 
HrQoL as a dynamic construct (Taylor et al., 2008). Third, the capacity of children to answer 
long questionnaires, to understand response option scales, and to interpret different time 
spans may differ from adults. These challenges can be confronted by using questions and 
response formats suitable for children (e.g., smiley face scales for very young children), and 
conducting in-person interviews instead of paper-pencil surveys (Landolt & Sennhauser, 
2007).  
For all these reasons, the age-sensitivity of assessment instruments is most important. 
At the same time, age spans must not be chosen too narrow, so one can assess HrQoL with 
the same instrument over time as the person ages (Eiser & Jenney, 2007). Guidelines related 
to the use of paediatric patient-reported outcomes by Matza et al. (2013) point out that age 
considerations depend on many factors, like the population of interest and the form of data 
collection (paper-pencil, in-person interview). They also state that the developmental state of 
a child might not always match their chronological age. Nevertheless, they propose generally 
considering four age groups as best practice, based upon current, empirically-derived under-
standing (Matza et al., 2013):  
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(1) Younger than 5-years: in these children, there is no evidence of reliable self-
reporting, so only proxy-reporting is recommended.  
(2) 5-7 years: self-assessment is recommended, but should be interpreted with 
caution, due to uneven cognitive capacities between children and contradic-
tory findings about reliability in past studies. It is especially important to main-
tain clear formatting and age-appropriate vocabulary.  
(3) 8-11 years: Children in this age group have attained some level of understand-
ing of health concepts, and have a progressively-expanding cognitive ability 
to understand tasks. They also possess the regulatory ability to avoid distrac-
tions (Bevans, Riley, Moon, & Forrest, 2010). Moreover, there is growing ev-
idence that self-reporting is both feasible and reliable. Nonetheless, vigilance 
is warranted to ensure that such children understand the questions as intended. 
(4) 12-18 years: The reliability and feasibility of self-assessments do not differ 
significantly between adolescents and adults. However, capturing content va-
lidity for this age group must be considered as challenging, due to the unique 
social and emotional challenges that adolescents face. 
 
2.3. Quality of life in patients with IT-IEM 
Relative to other chronic diseases, research on psychosocial issues in IT-IEM patients 
has started relatively late and remains sparse, as reviewed in detail in part B of this thesis 
(Zeltner, Huemer, Baumgartner, & Landolt, 2014). The first publications are dated 2006 
(Simons et al., 2006) reporting on psychological adjustment, and 2007 (Packman et al., 2007) 
reporting on HrQoL. The delay to begin such research might be associated with the fact that 
the diagnosis and treatment of IT-IEM only emerged in recent years, so that suddenly there 
appeared a growing population of long-term survivors (Batshaw, Tuchman, Summar, & 
Seminara, 2014). Part B of this thesis reviews studies that assessed HrQoL, psychological 
adjustment, and adaptive functioning in IT-IEM patients up to April 2013 (Zeltner et al., 
2014). Additional studies have been published since then. One publication included as many 
as 152 patients with either a UCD or some form of OA (Jamiolkowski et al., 2016), in which 
HrQoL was measured using the generic tool PedsQL by either self-report (if patients were 
able to understand it) or proxy-report. HrQoL was reported to be in the same range as in the 
reference population. However, behavioural and emotional problems, identified during a 
standardized psychiatric interview (Esser, 1989), were identified. Another study that em-
ployed the PedsQL uncovered impaired HrQoL in patients with methylmalonic aciduria, a 
disease belonging to the OA group of disorders, relative to healthy children and children with 
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other chronic conditions, with lowest scores for school and social functioning (Splinter et al., 
2015). Thus, results on HrQoL in IT-IEM remain inconsistent, as in previous research 
(Zeltner et al., 2014). 
As described in our review (Zeltner et al., 2014), methodological shortcomings are a 
considerable limitation of previous research. Specifically, the lack of a validated, disease-
specific HrQoL instrument hampers any sensitive assessment of specific problems among 
IT-IEM patients. This gap was aimed to be filled by this dissertation project. The following 
chapter will elaborate on the methodological background that must be considered as one 
seeks to develop and evaluate a HrQoL questionnaire. 
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3.  Psychometric theory 
The development of instruments to measure constructs like HrQoL forces one to con-
front a variety of challenges, which can be addressed statistically via psychometric theory 
(Raykov & Marcoulides, 2011). One major challenge is that HrQoL is not directly measura-
ble; as such, it must be considered a construct or latent variable. HrQoL can be rendered 
measurable by defining indicators of the construct, like items (tasks or questions) in a ques-
tionnaire, representing behaviours or thoughts. This process of construct operationalisation 
has no single, valid solution (Raykov & Marcoulides, 2011). At the end of the operationali-
sation stage, a construct is represented by a sample of associated indicators, which can differ 
depending upon the investigators involved in the process. Another challenge of psychological 
assessments relates to the embedding of a construct of interest within the existing theoretical 
framework. In the case of developing a disease-specific HrQoL assessment tool, generic 
HrQoL measures and related constructs need to be taken into account and their relationships 
elaborated statistically; for example, by exploring correlations (Raykov & Marcoulides, 
2011). Finally, measurements in social science are subject to error. The approach of classical 
test theory, upon which most psychological tests are based, addresses this issue and will be 
discussed below.  
Keeping these challenges in mind, one can define psychometric theory as one that  
“deals with (a) evaluating the degree to which these problems affect behavioural measure-
ment in a given situation and (b) developing methods to overcome or minimize the adverse 
impact of these and related problems and challenges” (Raykov and Marcoulides 2011, p. 9).  
 
3.1. Classical test theory 
Classical test theory has its roots at the beginning of the last century (Spearman, 1904). 
Subsequently, it was developed further over many years (Raykov & Marcoulides, 2011). It 
is one of the theories upon which most commonly-used psychometric tests are based 
(Moosbrugger & Kelava, 2012). Classical test theory relies on several assumptions, its axi-
oms, among which the most important states that a measured score X is composed of a true 
score T and an error score E (Moosbrugger & Kelava, 2012):  
 
X = T + E 
 
The X is all that can be measured, while the true score T is what is of interest. Under 
the assumption of uncorrelated errors, T can be approximated by computing the mean of 
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multiple measurements (Moosbrugger & Kelava, 2012). Multiple measurements can be ob-
tained by repeatedly exposing the same test subject to the same item. However, this technique 
creates memory effects that may bias the result. Alternatively, computing the mean of differ-
ent items all referring to the same latent variable can allow one to approximate a true score T 
as well (Moosbrugger & Kelava, 2012). With respect to HrQoL, T could thereby be estimated 
using a questionnaire composed of several different items all acting as indicators of HrQoL.  
 
3.2. Quality criteria of psychological tests 
Quality criteria are applied to assess the quality of a test, as depicted in Figure 5 
(Moosbrugger & Kelava, 2012). They can be classified as either main or auxiliary quality 
criteria.  
Objectivity is the first main quality criteria, addressing the comparability of test results. 
A test must therefore be objectively related to its implementation, its evaluation, and its in-
terpretation (Moosbrugger & Kelava, 2012). Standardised assessment procedures, the train-
ing of individuals to assess and evaluate tests, and detailed manuals all may help to ensure 
objectivity (Bühner, 2011). To rate the evaluation’s objectivity, two evaluators could be 
given the same test material to work on, after which the results of their evaluation could be 
compared.  
Reliability, as the second main quality criteria, refers to the exactness of a measurement 
(Moosbrugger & Kelava, 2012). It is strongly associated with the assumptions of classical 
test theory (Raykov & Marcoulides, 2011), providing information about variance in the ob-
served score (Bühner, 2011). Basically, reliability can be measured by comparing different 
measurements and examining their inter-correlations. Different measurements are thereby 
obtained by repeating a test or by dividing a single test into different parts. Reliability has 
four main components (Moosbrugger & Kelava, 2012). Test-retest reliability is a measure of 
how strongly correlated scores for the same test are, when administered twice to the same 
participant within a set time interval. Importantly, this measurement is only meaningful if the 
construct measured is expected to be relatively stable over time, which would be the case for 
constructs like intellectual performance (intelligence) and personality traits (Bühner, 2011). 
Relevance of test-retest reliability during HrQoL assessments is more debatable, since 
HrQoL is, by definition, a dynamic construct that is sensitive to change over time (Taylor et 
al., 2008).  Furthermore, other influences like transfer or memory effects must be considered 
(Moosbrugger & Kelava, 2012), especially if the selected test-retest interval is short.  
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Figure 5: Quality criteria to evaluate psychological tests 
 
A second dimension of reliability is parallel-test reliability, which also requires that 
two measurements are made on the same subject. It can be computed by correlating the scores 
of parallel test forms, which consist of very similar items, also referred to as ’item twins’ 
(Moosbrugger & Kelava, 2012).  
Split-half reliability is a very useful way to assess a test’s reliability via one-time ad-
ministration. Each test item is assigned to one of two subtests, either the A or B half. The two 
halves are then correlated and the resulting coefficient typically optimised using a formula to 
consider the original length of the test (Bühner, 2011).  
Finally, internal consistency is an expansion of split-half reliability. To measure inter-
nal consistency, each item is considered a subtest, and internal consistency is roughly the 
mean of all their inter-correlations. It is usually assessed by computing Cronbach’s alpha 
(Bühner, 2011; Cronbach, 1951). Cronbach’s alpha also adjusts the resulting reliability coef-
ficient to consider the original test’s length, as with split-half reliability. 
Validity is a third essential quality criteria, which can be defined as the ability of a test 
to actually measure the construct it was designed to evaluate (Raykov & Marcoulides, 2011). 
As with reliability, validity has four dimensions. Content validity refers to the extent to which 
a measure reflects the underlying theoretical construct in a qualitative way. One potential 
way to evaluate content validity is to ask experts to examine the test to determine how accu-
rately they perceive its items measure the construct of interest (Moosbrugger & Kelava, 
2012). However, since multiple definitions often exist for the same construct in the social 
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sciences, content validity can sometimes be disputed among experts (Raykov & Marcoulides, 
2011).  
A second component of validity is face validity, which refers to how easily laypersons 
recognize the construct measured by a test (Moosbrugger & Kelava, 2012).  
Construct validity refers to the theoretical foundation of a construct, which can be 
measured by different means (Moosbrugger & Kelava, 2012). One way is to determine how 
well the instrument agrees with other measures that quantify the same or a similar construct, 
a characteristic termed convergent validity. The flip side to this is discriminant validity, 
which assesses how well the construct of interest is distinctive relative to other constructs. 
Construct validity also be can evaluated by means of either exploratory or confirmatory factor 
analytical procedures that seek to detect or verify the construct’s dimensionality.  
The fourth validity dimension is called criterion validity, which refers to the test’s prac-
tical use. A test exhibits high criterion validity if its scores are able to predict some behaviour 
(the criterion) that extends beyond the test; one example of this would be using an intelligence 
test score as an indicator of school grades.  
Besides these main quality criteria, several auxiliary quality criteria are needed to thor-
oughly evaluate a psychological test. A test should have valid instructions for scoring and 
scaling of items (Bühner, 2011). Furthermore, it should be possible to compare a participant’s 
score against a normative population, which is attained by standardising the test (Bühner, 
2011). Additionally, the test’s cost, utility and feasibility must be evaluated. One final auxil-
iary criterion refers to the potential for falsification. It should not be possible for test partici-
pants to falsify their test score; for example, for them to somehow fake high intelligence 
during an intellectual performance test (Bühner, 2011) or feign psychosocial characteristics 
that they do not have beyond the confines of the test. 
 
All of the afore-mentioned criteria help to describe both the quality of a test and its 
potential limitations. However, the importance and rating of a single criterion differs, de-
pending on the area of application. As such, reliability in engineering is expected to be much 
higher than in psychology. This is because psychological constructs can be operationalised 
differently by different researchers and measurement is much more vulnerable to error, since 
it can be influenced by factors like the test subject’s mood or performance on the test day. 
Furthermore, it is important to note that, sometimes, decisions must be made to rate 
one quality criterion as more important than another. For example, virtually perfect reliability 
can be achieved by using almost identical test items. An example of this would be using the 
following three questions — 1. Do your medications bother you? 2. Does taking medication 
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bother you? 3. Do you hate taking your medication? — in the same questionnaire. Almost 
without question, responses to these three items will almost always agree. On the other hand, 
it is unlikely that these three items adequately address the breadth of the construct of interest 
(e.g., drug compliance); as such, the content validity of an instrument restricted to these three 
items would likely be very low (Bühner, 2011).  
Another possible trade-off may be between objectivity and feasibility. Especially in 
paediatric research, it may be necessary to interview test participants in person, rather than 
let them complete a test by themselves, in order to increase a test’s feasibility and verify the 
participants’ understanding of questions. However, doing so may adversely affect the objec-
tivity of the test results, since they might be influenced by characteristics of the different 
interviewers. 
In the field of paediatric HrQoL measurement, the quality of instruments can be eval-
uated using all of the quality criteria. However, how the different criteria are weighted, in 
terms of their importance, warrants attention. In children, for example, a test’s feasibility is 
paramount. Additionally, the complexity of the HrQoL construct begs special attention re-
lated to validity. Standardisation might be more important in generic HrQoL instruments de-
signed to compare different populations, while disease-specific instruments must be 
constructed paying utmost attention to content validity, since the content of such a question-
naire will invariably differ from the wide range of generic questionnaires that already are 
available.  
To date, various generic HrQoL questionnaires have been proven to be psychometri-
cally sound (e.g., The KIDSCREEN Group Europe, 2006; Varni et al., 1999; Vogels et al., 
1999). Furthermore, many disease-specific instruments have been developed in recent years 
(Solans et al., 2008). However, a psychometrically-evaluated assessment tool for IT-IEM 
could not be identified (Zeltner et al., 2014). A targeted assessment of the disease burdens of 
IT-IEM patients was therefore not yet possible up to now. This gap is, hopefully, filled by 
this dissertation that aimed to both develop and validate such an instrument. The next chapter 
will offer an overview of the development process embedded in the dissertation project.  
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4. Overview of the present dissertation project 
This dissertation project was established and funded by the Clinical Research Priority 
Program radiz – Rare Disease Initiative Zurich. Work was conducted from spring 2013 to 
autumn 2016. radiz has sought to have researchers of various rare diseases join forces to 
address a common goal: to “improve the treatment and outcomes of patients with rare dis-
eases” (www.radiz.uzh.ch). Consistent with the radiz mandate, the final goal of this disserta-
tion was to develop a disease-specific questionnaire to assess HrQoL in paediatric IT-IEM 
patients. The project was characterized by interdisciplinary cooperation between psycholo-
gists and physicians at metabolic centres in Dusseldorf, Hamburg, Heidelberg, Innsbruck, 
and Zurich. This international cooperation was particularly valuable, not only to increase the 
sample of IT-IEM patients, but also to harness multiple perspectives from investigators at 
different centres.  
Having provided theoretical backgrounds for IT-IEM and HrQoL, and addressed meth-
odological issues pertaining to their study in part A of this thesis, part B consist of three 
publications, all of which were written during the current project’s time-frame. The first of 
the two publications and, hence, the first of the three chapters is a systematic review that 
elaborates on the current state of research in the field. The second paper and chapter presents 
the results of the content analysis of focus group interviews with patients and parents. These 
results ultimately formed the foundation for questionnaire development. The third chapter, 
describes the development and psychometric evaluation of the MetabQoL 1.0, the HrQoL 
instrument for IT-IEM patients that was developed within the confines of the current thesis 
project. How the publications are organized in the context of the current project is depicted 
in Figure 6. The dissertation concludes with a part C discussing the questionnaire develop-
ment process, the quality of the resulting MetabQoL 1.0, potential directions for future re-
search, and the clinical implications of the work presented here.   
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Figure 6: Flowchart of the present dissertation project with its resulting publications 
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1. Health-related quality of life, psychological adjustment, and adaptive 
functioning of patients with intoxication-type inborn errors of metab-
olism – a systematic review 
 
 
Reference: Zeltner, N. A., Huemer, M., Baumgartner, M. R., Landolt M. A. (2014). Quality 
of Life, Psychological Adjustment, and Adaptive Functioning of Patients with Intoxication-
type Inborn Errors of Metabolism – a Systematic Review. Orphanet Journal of Rare Dis-
eases, 9(1): 159. doi: 10.1186/s13023-014-0159-8 
 
1.1. Abstract 
Background: In recent decades, considerable progress in diagnosis and treatment of 
patients with intoxication-type inborn errors of metabolism (IT-IEM) such as urea cycle dis-
orders (UCD), organic acidurias (OA), maple syrup urine disease (MSUD), or tyrosinemia 
type 1 (TYR 1) has resulted in a growing group of long-term survivors. However, IT-IEM 
still require intense patient and caregiver effort in terms of strict dietetic and pharmacological 
treatment, and the threat of metabolic crises is always present. Furthermore, crises can affect 
the central nervous system (CNS), leading to cognitive, behavioural and psychiatric sequelae. 
Consequently, the well-being of the patients warrants consideration from both a medical and 
a psychosocial viewpoint by assessing health-related quality of life (HrQoL), psychological 
adjustment, and adaptive functioning. To date, an overview of findings on these topics for 
IT-IEM is lacking. We therefore aimed to systematically review the research on HrQoL, psy-
chological adjustment, and adaptive functioning in patients with IT-IEM.  
Methods: Relevant databases were searched with predefined keywords. Study selection 
was conducted in two steps based on predefined criteria. Two independent reviewers com-
pleted the selection and data extraction. 
Results: Eleven articles met the inclusion criteria. Studies were of varying methodo-
logical quality and used different assessment measures. Findings on HrQoL were incon-
sistent, with some showing lower and others showing higher or equal HrQoL for IT-IEM 
patients compared to norms. Findings on psychological adjustment and adaptive functioning 
were more consistent, showing mostly either no difference or worse adjustment of IT-IEM 
patients compared to norms. Single medical risk factors for HrQoL, psychological adjustment 
or adaptive functioning have been addressed, while psychosocial risk factors have not been 
addressed. 
Conclusion: Data on HrQoL, psychological adjustment, and adaptive functioning for 
IT-IEM are sparse. Studies are inconsistent in their methodological approaches, assessment 
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instruments and norm populations. A disease-specific standard assessment procedure for 
HrQoL is not available. Psychosocial risk factors for HrQoL, psychological adjustment, or 
adaptive functioning have not been investigated. Considering psychosocial variables and 
their corresponding risk factors for IT-IEM would allow evaluation of outcomes and treat-
ments as well as the planning of effective social and psychological interventions to enhance 
the patients’ HrQoL. 
 
1.2. Introduction 
Intoxication-type inborn errors of metabolism (IT-IEM) are a group of inborn errors of 
metabolism (IEM) which share distinct clinical features. The group encompasses urea cycle 
disorders (UCD), organic acidurias (OA), tyrosinemia type 1 (TYR 1), and maple syrup urine 
disease (MSUD). The estimated incidence is about 1:35’000 for UCD (Marshall L Summar 
et al., 2013), about 1:21,000 for OA (Dionisi-Vici et al., 2002), about 1:100,000 for TYR 1 
(De Laet et al., 2013) and about 1:185,000 for MSUD (Chuang & Shih, 2001).  
Patients with IT-IEM share two main clinical features: they have to follow a strict diet, 
and they live with the permanent risk of metabolic crises. These can be triggered by altera-
tions in diet, common infections, or stress but may also occur without predictive circum-
stances. In cases of metabolic crises, patients immediately require intensified home care or 
hospitalisation. Despite such efforts, crises remain life-threatening and may cause organ and 
central nervous system (CNS) damage (Walterfang, Bonnot, Mocellin, & Velakoulis, 2013). 
To ensure correct diet and an appropriate reaction in risk situations, patients and their families 
are obliged to develop extensive knowledge about the disease.  
Intense biomedical research in the field of IT-IEM has resulted in substantial advances 
in treatment and a growing group of surviving patients (J. S. Cohen & Biesecker, 2010). 
These individuals have to cope with stressors such as strict diet, medication, crises manage-
ment, and uncertainties about the future course of their disease and its consequences. Fur-
thermore patients may have behavioural, cognitive, or psychiatric problems due to the CNS 
alterations caused by the disease (Walterfang et al., 2013), which again impair their psycho-
logical functioning (Dey, Landolt, & M., 2012; Fan, Eiser, & Ho, 2010). As a result, even 
though treatments have improved, IT-IEM affect the daily life and well-being of patients and 
their caregivers considerably (Weber, Segal, & Packman, 2012). Therefore, complementary 
research from a psychosocial perspective is especially needed (Gentile, Ten Hoedt, & Bosch, 
2010; Weber et al., 2012).  
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Health-related quality of life (HrQoL), psychological adjustment, and adaptive func-
tioning are well-established constructs to describe psychosocial consequences of chronic dis-
eases. HrQoL has been defined as “a patient’s perception of the impact of disease and 
treatment on functioning in a variety of dimensions, including physical, psychological and 
social domains” (Varni, Seid, & Rode, 1999, p. 126). Adjustment describes the healthy re-
balancing of patients to a new condition (De Ridder, Geenen, Kuijer, & van Middendorp, 
2008). We use the more specific term psychological adjustment to refer specifically to emo-
tional, behavioural or social adjustment to a disease. Finally, adaptive functioning is a related 
term describing “the performance of daily activities required for personal and social suffi-
ciency” (Sparrow, Cicchetti, & Balla, 2005, p. 6), consisting of the three domains conceptual, 
practical and social functioning (American Association on Mental Retardation (AAMR), 
2002). To date, no consensus has arisen about how HrQoL, psychological adjustment, and 
adaptive functioning are affected in IT-IEM patients and what factors can influence the well-
being of the patients. An overview of findings is lacking. For this reason, we decided to 
systematically review the current research on HrQoL, psychological adjustment, and adap-
tive functioning in IT-IEM patients. Our purpose was to answer two research questions:  
(1)  What is the current state of knowledge about self- and proxy-reported HrQoL, 
psychological adjustment, and adaptive functioning in IT-IEM patients?   
(2)  What are the medical and psychosocial risk factors for HrQoL, psychological 
adjustment, and adaptive functioning in IT-IEM patients? 
 
1.3. Methods 
Data sources and search strategies 
To identify eligible studies for our review, we searched relevant databases with pre-
defined search terms. The search was conducted using the following electronic bibliographic 
databases up to 30 April 2013: Pubmed, Embase, Cinahl, PsycINFO, Psyndex and the 
Cochrane Database of Clinical Trials and Systematic Reviews. NDLTD (Networked Digital 
Library of Theses and Dissertations) and dissonline.de were searched to find eligible disser-
tations. We applied two groups of search terms. Firstly, we employed various disease names 
referring to IEM and IT-IEM. Secondly, we referred to HrQoL, psychological adjustment, 
and adaptive functioning by employing these terms: quality of life, life satisfaction, well be-
ing, well-being, wellbeing, adjustment, adaption, adaptation, adaptive, psycholog*, psycho-
social, psychiatr*, social, emotional, mental health, mental disorder, mental disease, 
behavior*, behaviour*. To augment the specificity of the search, the IEM / IT-IEM group 
and the HrQoL / psychological adjustment / adaptive functioning group were connected to 
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each other by the Boolean operator “AND”, whereas terms within the groups were connected 
by the Boolean operator “OR”. We also took advantage of other options to refine the search 
when the databases offered them; accordingly, search terms concerning IEM, HrQoL, psy-
chological adjustment, and adaptive functioning were limited to titles and abstracts, and 
words with multiple possible endings or spellings were completed by wildcards. An addi-
tional search for studies was conducted in two ways. First, to minimise publication bias, ex-
perts in the field were contacted via e-mail and asked if they were aware of any relevant 
articles or unpublished data. In addition, the references of relevant articles were screened.  
 
Study selection 
To find eligible studies, we rated all the articles and dissertations found in our system-
atic search according to pre-defined inclusion and exclusion criteria. Studies were included 
if the number of participants was N > 1 and if the sample contained at least 50% IT-IEM 
patients or if the results of IT-IEM patients were reported separately. Outcomes had to in-
clude a self-, proxy, or examiner’s report of patients’ HrQoL, patients’ psychological adjust-
ment (psychological, social, behavioural or emotional adjustment), or adaptive functioning. 
The assessment of these outcomes had to be completed in a standardised way and reported 
quantitatively. Reporting of methods and results had to be sufficient for replicability. Finally, 
reports were accepted if they were written in English, German, French or Spanish. Articles 
not fulfilling these criteria were excluded. The selection process was conducted in two major 
steps. First, one reviewer (N.A.Z.) examined all titles and abstracts. Second, studies that 
could not be excluded in the first examination were rated in their full-text version by two 
reviewers (N.A.Z. and M.H.) independently. Inter-rater reliability was substantial (Landis & 
Koch, 1977), with Cohen’s kappa = 0.79. Any disagreements were arbitrated through discus-
sion. The remaining articles were included for data extraction.  
 
Data extraction and analysis 
Two reviewers (N.A.Z and M.A.L) extracted the data of the articles independently. 
Inter-rater reliability was almost perfect (Landis & Koch, 1977), with Cohen’s kappa = 0.98. 
Disagreements were resolved through discussion. The great variation between studies regard-
ing design, such as measures and reporting of results, did not permit statistical pooling of 
data from the individual studies, so meta-analytic calculations were not possible. Instead, 
effect sizes were calculated whenever possible to attain some comparability between the re-
sults. Standardised mean differences, including 95% confidence intervals (CI), were calcu-
lated for continuous outcomes using Cohen’s d effect sizes, corrected for small sample sizes 
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(Durlak, 2009). An effect size was considered to be significant if its 95% CI did not include 
0, thus considering a significance level of p < .05. According to Cohen’s categories, an effect 
size is small if d = 0.2 - 0.5, medium if d = 0.5 - 0.8 and large if d > 0.8 (J. Cohen, 1988). 
Calculations were conducted such that a positive Cohen’s d stands for a higher scoring of the 
IT-IEM group than of norms. Higher scorings are favourable for all scales, except for two 
cases: the Child Behaviour Checklist (CBCL) and the Behaviour Assessment System for 
Children (BASC) (all subscales but adaptive skills) report problem behaviour. Consequently, 
higher scores signify more problems and are unfavourable outcomes. For dichotomous out-
comes, we used Chi-square tests, indicating the strength of the association by Cramer’s V, 
with p < .05 considered significant. IBM SPSS Statistics for Windows, Version 20.0 was 
used for all calculations.  
 
1.4. Results 
The initial search of databases revealed 1669 articles and dissertations. After the first 
selection, 20 articles remained. During the second selection process, we had to exclude an-
other nine articles; three were single-case reports, one had the same sample as another article 
included, and seven articles lacked standardised assessments of the patients’ HrQoL, psycho-
logical adjustment, or adaptive functioning. One of these articles was a qualitative study 
(Packman et al., 2012). One additional, recently published article (Gramer et al., 2013) was 
found by contacting experts in the field, and another was traced (Mazariegos et al., 2012) by 
screening the references of relevant studies. The search and selection process is depicted in 
Figure 1. Finally, 11 articles remained for further analyses. 
 
Study description 
The main characteristics and results of the articles included in our review are summa-
rised in Table 1. Further information about the assessment instrument used in the studies can 
be found in Table 2. Detailed analyses of outcome parameters are shown in Tables 3 and 4. 
All 11 articles were published between 2006 and 2013, seven of them in 2012 or 2013. Four 
articles have their origins in the United States, two in Germany and one each in Australia, 
Belgium, Italy, Poland and Turkey. All articles are written in English. All of the four disease 
groups we searched for (UCD, OA, MSUD, TYR 1) are represented in the final selection of 
studies. Patients diagnosed with MSUD (n = 124) represent the largest group, followed by 
OA (n =107), UCD (n = 100) and TYR 1 (n = 11). Seven studies reported outcomes for only 
one of these disease groups, four studies included patients of multiple groups. From six arti-
cles, only subgroup data were extracted. In four studies, we selected IT-IEM patients from 
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the original samples, which integrated patients with IT-IEM and patients with other diseases 
(Cazzorla et al., 2012; Eminoglu, Soysal, Tumer, Okur, & Hasanoglu, 2013; Gramer et al., 
2013; Simons et al., 2006). One study reported on IT-IEM patients before and after trans-
plantation. Only the subgroup before transplantation was selected for further analysis 
(Muelly et al., 2013). In another study, outcome regarding adaptive functioning was only 
available for a subgroup (Mazariegos et al., 2012). The final sizes considered ranged from N 
= 4 to N = 92 patients.  
Many of the studies had methodological limitations. One main weakness is the lack of 
appropriate participant selection (i.e. use of convenience samples) in order to avoid selection 
or non-response bias (Beauchamp, Boneh, & Anderson, 2009; Cazzorla et al., 2012; 
Eminoglu et al., 2013; Grünert et al., 2013; Krivitzky et al., 2009; Muelly et al., 2013; 
Packman et al., 2007; Pohorecka et al., 2012). Two studies involved a non-validated meas-
uring tool (Eminoglu et al., 2013; Gramer et al., 2013). Furthermore, only two studies con-
sidered multiple informants in terms of self- and proxy-ratings (Packman et al., 2007; Simons 
et al., 2006).  
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Table 1: Main characteristics of the reviewed studies 
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rm
s:
 s
ig
n.
 h
ig
he
r 
Q
oL
 fo
r p
hy
si
ca
l d
om
ai
n,
 lo
w
er
 fo
r 
en
vi
ro
nm
en
ta
l d
om
ai
n,
 n
o 
si
gn
. 
gr
ou
p 
di
ffe
re
nc
e 
fo
r a
ll 
ot
he
r d
o-
m
ai
ns
 
• Q
oL
 (W
H
O
Q
O
L-
10
0)
: C
om
pa
re
d 
to
 o
th
er
 IE
M
: n
o 
si
gn
. g
ro
up
 d
iff
er
-
en
ce
 c
om
pa
re
d 
to
 P
KU
 fo
r a
ll 
do
-
m
ai
ns
, s
ig
n.
 h
ig
he
r c
om
pa
re
d 
to
 
M
or
bu
s 
Fa
br
y 
an
d 
ph
ar
m
ac
ol
og
i-
ca
lly
 tr
ea
te
d 
pa
tie
nt
s 
in
 m
os
t d
o-
m
ai
ns
 (n
o 
si
gn
. g
ro
up
 d
iff
er
en
ce
 fo
r 
so
ci
al
 a
nd
 e
nv
iro
nm
en
ta
l d
om
ai
ns
) 
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Table 1: Main characteristics of the reviewed studies (continued) 
 E
m
in
og
lu
 e
t a
l.,
 
20
13
 (T
ur
ke
y)
 
M
A,
 P
A,
 
M
SU
D
, T
YR
  
(g
ro
up
 in
-
cl
ud
es
 n
 =
 3
 
pa
tie
nt
s 
w
ith
 
a 
di
se
as
e 
no
t 
be
in
g 
an
 IT
-
IE
M
) 
14
 
R
ev
ie
w
ed
 s
am
pl
e:
 
se
pa
ra
te
ly
 re
po
rte
d 
su
bg
ro
up
, m
ai
nl
y 
IT
-
IE
M
, 3
 o
th
er
 IE
M
 
O
rig
. s
am
pl
e:
 IT
-IE
M
 
m
ix
ed
 w
ith
 o
th
er
 IE
M
 
(N
 =
 6
8)
 
4.
7 
(n
.a
., 
SD
 =
 4
.3
) 
Po
pu
la
tio
n 
no
rm
s,
 o
th
er
 
IE
M
-g
ro
up
s:
 
C
M
D
 a
nd
 A
M
D
 
• Q
ue
st
io
nn
ai
re
 
co
ns
tru
ct
ed
 b
y 
au
th
or
s:
 Q
oL
 
Sc
al
e 
fo
r M
et
a-
bo
lic
 D
is
ea
se
s 
(p
ro
xy
-p
ar
en
t) 
• K
id
dy
-, 
Ki
d-
 
Ki
dd
o-
KI
N
D
L 
(p
ro
xy
-p
ar
en
t, 
se
lf 
if 
>=
 4
ye
ar
s)
 
• H
rQ
oL
 (Q
oL
 S
ca
le
 fo
r M
et
ab
ol
ic
 
D
is
ea
se
s)
: S
ig
n.
 lo
w
er
 c
om
pa
re
d 
to
 
C
M
D
 a
nd
 A
M
D
 fo
r s
ch
oo
l s
ta
tu
s 
an
d 
he
al
th
 p
er
ce
pt
io
n 
do
m
ai
ns
, s
ig
n.
 
Lo
w
er
 in
 p
hy
si
ca
l f
un
ct
io
n 
do
m
ai
n 
co
m
pa
re
d 
to
 A
M
D
, s
im
ila
r f
or
 o
th
er
 
do
m
ai
ns
 
• H
rQ
oL
 (K
IN
D
L)
: N
o 
si
gn
. g
ro
up
 
di
ffe
re
nc
e 
co
m
pa
re
d 
to
 C
M
D
 a
nd
 
AM
D
 fo
r e
m
ot
io
na
l w
el
lb
ei
ng
 d
om
ai
n 
G
ra
m
er
 e
t a
l.,
 
20
13
 (G
er
m
an
y)
 
AS
LD
, G
A 
I, 
IV
A,
 P
A,
 
M
SU
D
 
34
 
R
ev
ie
w
ed
 s
am
pl
e:
 
on
ly
 IT
-IE
M
 
O
rig
. s
am
pl
e:
 IT
-IE
M
 
m
ix
ed
 w
ith
 o
th
er
 IE
M
 
(N
 =
 1
87
) 
4 
(1
.2
 to
 
9.
7)
 
N
on
e 
Q
ue
st
io
nn
ai
re
 
co
ns
tru
ct
ed
 b
y 
au
th
or
s,
 a
s-
se
ss
in
g:
  
• P
er
ce
iv
ed
 b
ur
-
de
n 
fo
r t
he
 c
hi
ld
 
(p
ro
xy
-p
ar
en
t) 
• S
oc
ia
l b
eh
av
io
r 
(p
ro
xy
-p
ar
en
t) 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t (
Pe
r-
ce
iv
ed
 b
ur
de
n 
fo
r t
he
 c
hi
ld
): 
R
at
ed
 a
s 
lo
w
 fo
r t
he
 m
aj
or
ity
 (5
0%
)  
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t (
So
-
ci
al
 b
eh
av
io
ur
): 
R
at
ed
 a
ve
ra
ge
 fo
r 
th
e 
m
aj
or
ity
 (8
2%
)  
G
rü
ne
rt 
et
 a
l.,
 
20
13
 (G
er
m
an
y)
 
PA
 
48
 
Sa
m
e 
5 
(5
da
ys
 to
 
19
) 
 • F
or
 K
id
-
Ki
nd
l: 
11
 
(5
 to
 1
8)
 
• F
or
 S
D
Q
: 
4 
(1
 to
 1
8)
 
Po
pu
la
tio
n 
no
rm
s 
• K
id
-K
IN
D
L 
(s
el
f):
 
n 
= 
18
 
• S
D
Q
 (p
ro
xy
-p
ar
-
en
t):
 n
 =
 4
8 
 
 n 
ac
co
rd
in
g 
to
 
ag
e 
or
 d
eg
re
e 
of
 
m
en
ta
l r
et
ar
da
tio
n 
• H
rQ
oL
 (K
IN
D
L)
: S
ig
n.
 L
ow
er
 
H
rQ
oL
 fo
r p
sy
ch
ol
og
ic
al
 a
nd
 fr
ie
nd
s 
do
m
ai
n,
 s
ig
n.
 h
ig
he
r f
or
 s
ch
oo
l d
o-
m
ai
n,
 n
o 
gr
ou
p 
di
ffe
re
nc
e 
fo
r o
th
er
 
do
m
ai
ns
 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t 
(S
D
Q
): 
M
or
e 
pr
ob
le
m
s 
in
 a
ll 
sc
al
es
 
ex
ce
pt
 c
on
du
ct
 p
ro
bl
em
s 
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 Table 1: Main characteristics of the reviewed studies (continued) 
 K
riv
itz
ky
 e
t a
l.,
 
20
09
 (U
S
A
) 
U
C
D
 
92
 
Sa
m
e 
7.
2 
(0
.4
 to
 
16
.7
5)
 
Po
pu
la
tio
n 
no
rm
s 
• A
BA
S 
(p
ro
xy
-
pa
re
nt
): 
al
l a
ge
s 
• C
BC
L 
(p
ro
xy
-
pa
re
nt
): 
fo
r a
ge
s 
3-
16
 
• A
da
pt
iv
e 
fu
nc
tio
ni
ng
 (A
B
AS
): 
G
en
er
al
 s
co
re
 w
as
 s
ig
n.
 lo
w
er
 fo
r a
ll 
IT
-IE
M
 g
ro
up
s 
(n
eo
na
ta
l o
ns
et
, l
at
e 
on
se
t, 
pa
tie
nt
s 
w
ith
 / 
w
ith
ou
t h
yp
er
-
am
m
on
em
ic
 h
is
to
ry
) i
n 
th
e 
ag
e 
of
 3
-
16
 y
ea
rs
   
• A
da
pt
iv
e 
fu
nc
tio
ni
ng
 (A
B
AS
): 
G
en
er
al
 s
co
re
 w
as
 s
ig
n.
 lo
w
er
 fo
r 
th
e 
IT
-IE
M
 p
at
ie
nt
s 
w
ith
 a
 h
yp
er
am
-
m
on
em
ic
 h
is
to
ry
, n
ot
 fo
r t
he
 o
th
er
 
su
bg
ro
up
s,
 in
 th
e 
ag
e 
gr
ou
p 
of
 <
 3
 
ye
ar
s 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t 
(C
B
C
L)
: N
o 
si
gn
. g
ro
up
 d
iff
er
en
ce
 in
 
in
te
rn
al
is
in
g 
an
d 
ex
te
rn
al
is
in
g 
pr
ob
-
le
m
s 
M
az
ar
ie
go
s 
et
 
al
., 
20
12
 (U
S
A
) 
M
SU
D
 
31
 
R
ev
ie
w
ed
 s
am
pl
e:
 
Pa
tie
nt
s 
w
ith
 re
su
lts
 
fo
r a
da
pt
iv
e 
fu
nc
tio
n-
in
gO
rig
. s
am
pl
e:
 P
a-
tie
nt
s 
w
ith
 a
nd
 w
ith
ou
t 
re
su
lts
 fo
r a
da
pt
iv
e 
fu
nc
tio
ni
ng
 (N
 =
 3
5)
 
9.
9 
(1
.7
 to
 
32
.1
)  
(fo
r 
N
 =
 3
5)
 
Po
pu
la
tio
n 
no
rm
s 
• A
BA
S 
(s
el
f) 
or
 
Vi
ne
la
nd
 (s
el
f) 
(fo
r 
th
is
 re
vi
ew
: o
nl
y 
pr
e-
tra
ns
pl
an
ta
-
tio
n 
as
se
ss
m
en
t) 
• A
da
pt
iv
e 
fu
nc
tio
ni
ng
 (A
B
AS
 o
r 
Vi
ne
la
nd
): 
Si
gn
. l
ow
er
 s
co
re
 fo
r 
ad
ap
tiv
e 
fu
nc
tio
ni
ng
• R
is
k 
fa
ct
or
 
as
se
ss
m
en
t: 
Si
gn
 p
os
iti
ve
 c
or
re
la
-
tio
n 
be
tw
ee
n 
IQ
 a
nd
 a
da
pt
iv
e 
fu
nc
-
tio
n•
 R
is
k 
fa
ct
or
 a
ss
es
sm
en
t: 
N
o 
si
gn
. c
or
re
la
tio
n 
be
tw
ee
n 
ad
ap
tiv
e 
te
st
 s
co
re
s 
an
d 
ag
e 
at
 d
ia
gn
os
is
, 
nu
m
be
r o
f p
re
ce
di
ng
 m
et
ab
ol
ic
 c
ri-
se
s,
 n
um
be
r o
f h
os
pi
ta
liz
at
io
ns
, a
ge
 
at
 tr
an
sp
la
nt
at
io
n 
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 Table 1: Main characteristics of the reviewed studies (continued) 
 M
ue
lly
 e
t a
l.,
 
20
13
 (U
S
A
) 
M
SU
D
 
26
 
R
ev
ie
w
ed
 s
am
pl
e:
 IT
-
IE
M
 p
at
ie
nt
s 
on
 d
ie
t, 
no
t l
iv
er
-tr
an
sp
la
nt
ed
 
O
rig
. s
am
pl
e:
 IT
-IE
M
 
pa
tie
nt
s 
on
 d
ie
t a
nd
 
IT
-IE
M
 a
fte
r l
iv
er
 
tra
ns
pl
an
ta
tio
n 
(N
 =
 
37
) 
• F
or
 
M
SU
D
 d
ie
t 
n 
= 
26
: 
n.
a.
, M
dn
 
= 
19
.5
 (7
 
to
 3
5)
 
• F
or
 c
on
-
tro
ls
 n
 =
 
26
: n
.a
., 
M
dn
 =
 
15
.9
 (6
 to
 
35
) 
H
ea
lth
y 
co
nt
ro
l 
gr
ou
p 
(m
os
tly
 
si
bl
in
gs
 o
f 
M
SU
D
-p
at
ie
nt
s)
 
• S
C
ID
 (a
du
lt 
or
 
ch
ild
ho
od
 v
er
si
on
) 
fo
r D
SM
-IV
: d
e-
pr
es
si
on
, a
nx
ie
ty
, 
AD
H
D
, g
lo
ba
l, 
so
-
ci
al
, o
cc
up
at
io
na
l 
an
d 
ps
yc
ho
lo
gi
ca
l 
fu
nc
tio
ni
ng
 (s
el
f) 
 • B
D
I a
nd
 B
AI
 o
r 
su
b-
sc
or
es
 o
f t
he
 
BY
I o
f e
m
ot
io
na
l 
an
d 
so
ci
al
 Im
pa
ir-
m
en
t (
se
lf)
 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t (
Se
-
ve
rit
y 
of
 d
ep
re
ss
io
n 
an
d 
An
xi
et
y,
 
B
D
I, 
B
AI
, B
YI
): 
N
o 
si
gn
. g
ro
up
 d
if-
fe
re
nc
e 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t (
C
ur
-
re
nt
 a
nd
 li
fe
tim
e 
de
pr
es
si
on
 a
nd
 
an
xi
et
y,
 D
SM
-IV
): 
Si
gn
. m
or
e 
lif
e-
tim
e 
de
pr
es
si
on
 a
nd
 a
nx
ie
ty
 
 • R
is
k 
fa
ct
or
 a
ss
es
sm
en
t: 
Pa
tie
nt
 
w
ho
 re
m
ai
ne
d 
as
ym
pt
om
at
ic
 
th
ro
ug
ho
ut
 n
ew
bo
rn
 p
er
io
d 
vs
. p
a-
tie
nt
s 
w
ho
 w
er
e 
en
ce
ph
al
op
at
hi
c 
at
 
th
e 
tim
e 
of
 d
ia
gn
os
is
: S
ec
on
d 
gr
ou
p 
ha
s 
hi
gh
er
 ri
sk
 to
 la
te
r s
uf
fe
r f
ro
m
 
an
xi
et
y 
(5
x 
hi
gh
er
) a
nd
 fo
r d
ep
re
s-
si
on
 (1
0x
 h
ig
he
r)
 
• R
is
k 
fa
ct
or
 a
ss
es
sm
en
t: 
C
or
re
la
-
tio
n 
of
 m
oo
d 
di
st
ur
ba
nc
es
 w
ith
 s
om
e 
bi
oc
he
m
ic
al
 p
ar
am
et
er
s.
 N
o 
st
ro
ng
 
co
rre
la
tio
n 
of
 d
ep
re
ss
io
n 
an
d 
an
xi
-
et
y 
w
ith
 in
di
ce
s 
of
 li
fe
tim
e 
m
et
ab
ol
ic
 
co
nt
ro
l 
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 Table 1: Main characteristics of the reviewed studies (continued) 
 P
ac
km
an
 e
t a
l.,
 
20
07
 (U
S
A
) 
M
SU
D
 
55
 
Sa
m
e 
11
 (5
 to
 
18
) 
Po
pu
la
tio
n 
no
rm
s 
• B
AS
C
 (p
ro
xy
-
pa
re
nt
, p
ro
xy
-
te
ac
he
r)
 
• P
ed
sQ
L 
(s
el
f, 
pr
ox
y-
pa
re
nt
) 
• H
rQ
oL
 (P
ed
sQ
L)
: T
ot
al
 H
rQ
oL
 
sc
or
e 
an
d 
do
m
ai
ns
 a
re
 c
lo
se
r t
o 
ca
nc
er
 s
am
pl
e 
no
rm
s 
th
an
 to
 
he
al
th
y 
sa
m
pl
e 
no
rm
s 
 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t a
nd
 
ad
ap
tiv
e 
fu
nc
tio
ni
ng
 (B
AS
C
): 
M
os
tly
 n
o 
si
gn
. g
ro
up
 d
iff
er
en
ce
. 
Si
gn
. m
or
e 
pr
ob
le
m
s 
in
 s
om
e 
ar
ea
s,
 
si
gn
. l
ow
er
 s
co
re
s 
in
 a
da
pt
iv
e 
sk
ills
 
(p
ar
en
t- 
an
d 
te
ac
he
r-r
at
in
g)
 
 • S
el
f- 
vs
. p
ro
xy
-r
at
in
g:
 H
rQ
oL
 s
el
f-
re
po
rt 
> 
pr
ox
y-
re
po
rt 
fo
r p
hy
si
ca
l, 
em
ot
io
na
l, 
so
ci
al
 d
om
ai
n,
 n
o 
di
ffe
r-
en
ce
 fo
r s
ch
oo
l f
un
ct
io
n 
• S
el
f- 
vs
. p
ro
xy
-r
at
in
g:
 B
eh
av
-
io
ur
al
 a
dj
us
tm
en
t p
ro
xy
 p
ar
en
t- 
vs
. 
pr
ox
y 
te
ac
he
r-r
ep
or
t: 
pa
re
nt
 <
 
te
ac
he
r f
or
 in
te
rn
al
is
in
g 
pr
ob
le
m
s 
(s
om
at
iz
at
io
n,
 a
nx
ie
ty
) 
Po
ho
re
ck
a 
et
 a
l.,
 
20
12
 (P
ol
an
d)
 
TY
R
 I 
 
8 
Sa
m
e 
11
 (6
 to
 
15
) 
Po
pu
la
tio
n 
no
rm
s 
• C
BC
L 
(p
ro
xy
-p
a-
re
nt
) 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t 
(C
B
C
L)
: S
ig
n.
 m
or
e 
pr
ob
le
m
s 
in
 
se
ve
ra
l s
ca
le
s 
Si
m
on
s 
et
 a
l.,
 
20
06
 (B
el
gi
um
) 
O
TC
D
, G
A 
III
, 
M
M
A 
11
 
R
ev
ie
w
ed
 s
am
pl
e:
 
on
ly
 IT
-IE
M
 
O
rig
. s
am
pl
e:
 IT
-IE
M
 
m
ix
ed
 w
ith
 o
th
er
 IE
M
 
(N
 =
 5
3)
 
n.
a.
 (0
-2
 to
 
16
)  
 (fo
r N
 =
 
53
) 
Po
pu
la
tio
n 
no
rm
s 
• C
BC
L,
 T
R
F,
 
YS
R
 (p
ro
xy
-p
ar
-
en
t, 
pr
ox
y-
te
ac
he
r, 
se
lf 
if 
ch
ild
 >
 1
1y
ea
rs
 
ol
d)
 
• K
-S
AD
S 
fo
r 
D
SM
-IV
 d
ia
gn
os
is
 
(s
el
f) 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t 
(C
B
C
L)
: N
o 
si
gn
. g
ro
up
 d
iff
er
en
ce
 
• P
sy
ch
ol
og
ic
al
 a
dj
us
tm
en
t (
D
SM
-
IV
): 
Ps
yc
hi
at
ric
 d
ia
gn
os
es
 in
 n
 =
 2
, 
bu
t s
ca
le
 w
as
 n
ot
 a
pp
lie
d 
to
 th
e 
w
ho
le
 s
am
pl
e 
* T
he
 N
 re
po
rte
d 
co
rre
sp
on
ds
 to
 th
e 
hi
gh
es
t n
um
be
r o
f p
ar
tic
ip
an
ts
 fo
r w
hi
ch
 H
rQ
oL
 / 
ps
yc
ho
lo
gi
ca
l o
ut
co
m
e 
is
 re
po
rte
d.
 
**
 R
es
ul
ts
 a
re
 b
as
ed
 o
n 
th
e 
st
at
is
tic
 a
na
ly
si
s 
do
ne
 fo
r t
hi
s 
re
vi
ew
. A
 "s
ig
ni
fic
an
t" 
ou
tc
om
es
 m
ea
ns
 th
at
 th
e 
ca
lc
ul
at
ed
 9
5%
 C
I o
f t
he
 e
ffe
ct
 s
iz
e 
do
es
 
no
t i
nc
lu
de
 th
e 
va
lu
e 
of
 z
er
o 
an
d 
is
 th
us
 o
n 
a 
le
ve
l o
f  
p 
< 
0.
05
 (c
on
tin
uo
us
 re
su
lts
) o
r t
ha
t t
he
 χ
2-
te
st
 re
ve
al
ed
 a
 s
ig
ni
fic
an
t r
es
ul
t o
n 
a 
le
ve
l o
f p
 <
 0
.0
5 
or
 lo
w
er
 (d
ic
ho
to
m
ou
s 
re
su
lts
). 
Th
e 
st
at
em
en
ts
 re
fe
r t
o 
IT
-IE
M
 p
at
ie
nt
s 
re
la
te
d 
to
 th
e 
re
sp
ec
tiv
e 
gr
ou
p 
of
 c
om
pa
ris
on
. 
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 Table 1: Main characteristics of the reviewed studies (continued) 
 A
bb
re
vi
at
io
ns
 d
is
ea
se
s:
 A
M
D
 (A
m
in
o 
Ac
id
 M
et
ab
ol
is
m
 D
is
or
de
rs
), 
AS
A 
(A
rg
in
os
uc
ci
ni
c 
Ac
id
ur
ia
), 
AS
LD
 (A
de
ny
lo
su
cc
in
at
e 
Ly
as
e 
D
ef
ic
ie
nc
y)
, C
M
D
 
(C
ar
bo
hy
dr
at
e 
M
et
ab
ol
is
m
 D
is
or
de
rs
), 
G
A 
I (
G
lu
ta
ric
 A
ci
du
ria
 ty
pe
 I)
, G
A 
III
 (G
lu
ta
ric
 A
ci
du
ria
 ty
pe
 II
I),
 H
H
H
 S
yn
dr
om
 (H
yp
er
or
ni
th
in
em
ia
-H
yp
er
am
-
m
on
em
ia
-H
om
oc
itr
ul
lin
ur
ia
 S
yn
dr
om
e)
, I
EM
 (I
nb
or
n 
Er
ro
rs
 o
f M
et
ab
ol
is
m
), 
IV
A 
(Is
ov
al
er
ic
 A
ci
du
ria
), 
IT
-IE
M
 (I
nt
ox
ic
at
io
n-
ty
pe
 In
br
on
 E
rro
rs
 o
f M
et
ab
o-
lis
m
), 
M
M
A 
(M
et
hy
lm
al
on
ic
 A
ci
du
ria
), 
M
SU
D
 (M
ap
le
 S
yr
up
 U
rin
e 
D
is
ea
se
), 
O
TC
D
 (O
rn
ith
in
tra
ns
ca
rb
am
yl
as
e 
D
ef
ic
ie
nc
y)
, P
A 
(P
ro
pi
on
ic
 A
ci
du
ria
), 
TY
R
 I 
(T
yr
os
in
em
ia
 ty
pe
 I)
, U
C
D
 (U
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Table 2: Overview of assessment instruments used in the reviewed studies 
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Table 2: Overview of assessment instruments used in the reviewed studies (continued) 
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Table 2: Overview of assessment instruments used in the reviewed studies (continued) 
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Findings on HrQoL  
Self-report 
As shown in Table 3, results for self-reported HrQoL are inconsistent across studies. 
In one study, the authors reported significantly lower HrQoL for IT-IEM patients in most 
domains compared to population norms (Packman et al., 2007). The results for IT-IEM pa-
tients were closer to the results of a cancer population than to a healthy one. Two other studies 
showed results with more variance throughout the different HrQoL domains. One study re-
ported clearly lower scores for IT-IEM patients than for population norms in the psycholog-
ical and the friends domains, but higher scores for the school domain (Grünert et al., 2013). 
The results for other domains did not differ from norms. Half of the patients in the sample of 
this study did not categorise themselves as “ill”. In contrast, another group of researches 
reported significantly better scores in the physical domain for IT-IEM patients compared to 
population norms (Cazzorla et al., 2012), but lower scores in the environmental domain (in-
cluding e.g. financial resources, health care, physical environment). The same study found 
HrQoL of IT-IEM patients to be similar to that of patients with phenylketonuria, who also 
have to follow a strict diet but who do not face the risk of sudden metabolic crises. Further-
more, IT-IEM patients had higher HrQoL in most domains compared to Morbus Fabry pa-
tients, who often have to deal with pain symptoms, and patients with metabolic diseases under 
pharmacological (as opposed to dietary) treatment (Cazzorla et al., 2012).  
 
Proxy-report 
Proxy-ratings of HrQoL were all reported by parents. All results for IT-IEM patients 
were either not different from norms or unfavourable for IT-IEM patients (Table 3). One 
study showed significantly lower parent-rated HrQoL for IT-IEM patients across all domains 
compared to population norms (Packman et al., 2007). In line with the results for self-re-
ported HrQoL in the same study, the results were closer to cancer population norms than to 
healthy norms. Psychosocial and social domains were lower in IT-IEM patients than in the 
cancer population. In another article, the parent-rated HrQoL of IT-IEM patients was com-
pared with the parent-rated HrQoL of patients with other metabolic diseases (aminoacid met-
abolic disorders and carbohydrate metabolic disorders) (Eminoglu et al., 2013). IT-IEM 
patients scored lower in the domains of school functioning, health perception (compared with 
both diseases) and physical functioning (only compared with aminoacid metabolic disorders).  
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Table 3: Continuous outcomes in the reviewed studies 
Reference    CI of d  
N Instrument Subscale ES
1:  
Cohen's d  lower   upper sign. 
Health-related quality of life: self-report 
   Compared to  
population norms 
Cazzorla et al., 2012 WHOQOL-100 General n.a. n.a. to n.a. n.a. 
N = 15  Physical 0.62 0.10 to 1.13 * 
  Psychological 0.52 0.00 to 1.04 ns 
  Independence n.a. n.a. to n.a. n.a. 
  Social -0.13 -0.64 to 0.39 ns 
  Environmental -2.43 -2.97 to -1.89 * 
  Spiritual n.a. n.a. to n.a. n.a. 
  Medication n.a. n.a. to n.a. n.a. 
   Compared to  
PKU 
  General 0.03 -0.69 to 0.74 ns 
  Physical 0.16 -0.56 to 0.88 ns 
  Psychological 0.70 -0.04 to 1.44 ns 
  Independence -0.34 -1.06 to 0.38 ns 
  Social 0.14 -0.58 to 0.85 ns 
  Environmental 0.41 -0.31 to 1.14 ns 
  Spiritual 0.31 -0.41 to 1.04 ns 
  Medication 0.70 -0.04 to 1.44 ns 
   Compared to  
Morbus Fabry 
  General 1.15 0.35 to 1.95 * 
  Physical 1.49 0.65 to 2.33 * 
  Psychological 0.90 0.12 to 1.68 * 
  Independence 1.11 0.31 to 1.90 * 
  Social 0.70 -0.06 to 1.47 ns 
  Environmental 0.91 0.13 to 1.69 * 
  Spiritual 1.07 0.28 to 1.87 * 
  Medication -0.35 -1.10 to 0.40 ns 
   
Compared to  
IEM with pharmacological  
treatment 
  General 0.92 0.27 to 1.56 * 
  Physical 1.19 0.53 to 1.86 * 
  Psychological 0.94 0.30 to 1.59 * 
  Independence 0.74 0.11 to 1.38 * 
  Social 0.16 -0.46 to 0.78 ns 
  Environmental 0.75 0.12 to 1.39 * 
  Spiritual 0.90 0.25 to 1.54 * 
  Medication -0.26 -0.88 to 0.36 ns 
   Compared to  
population norms 
Grünert et al., 2013 KINDL Total -0.34 -0.81 to 0.12 ns 
N = 18  Physical -0.28 -0.74 to 0.19 ns 
  Psychological -0.78 -1.25 to -0.32 * 
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Table 3: Continuous outcomes in the reviewed studies (continued) 
  Self-esteem 0.15 -0.32 to 0.63 ns 
  Family -0.38 -0.84 to 0.09 ns 
  Friends -0.68 -1.14 to -0.21 * 
  School 0.73 0.22 to 1.24 * 
  Illness n.a. n.a. to n.a. n.a. 
   Compared to  
healthy population norms  
Packman et al., 2007 PedsQL self-report Physical function -0.28 -0.69 to 0.13 ns 
N = 55  Emotional function -0.55 -0.96 to -0.14 * 
  Social function -0.80 -1.22 to -0.39 * 
  School function -0.70 -1.12 to -0.29 * 
  Psychosocial -0.85 -1.27 to -0.44 * 
  Total  -0.77 -1.19 to -0.36 * 
   Compared to  
cancer population norms 
  Physical function 0.42 0.00 to 0.84 ns 
  Emotional function -0.04 -0.46 to 0.38 ns 
  Social function -0.24 -0.66 to 0.19 ns 
  School function -0.24 -0.67 to 0.18 ns 
  Psychosocial -0.23 -0.65 to 0.19 ns 
    Total  -0.02 -0.44 to 0.40 ns 
        
Health-related quality of life: proxy-report 
   Compared to  
CMD 
Eminoglu et al., 2013 QOL Scale for Meta-
bolic Disease 
Impact of IEM -0.18 -1.02 to 0.67 ns 
N = 14 Attention -0.42 -1.15 to 0.31 ns 
 Self-esteem about IEM 0.03 -0.70 to 0.76 ns 
  Physical function -0.65 -1.38 to 0.08 ns 
  Labeling -0.57 -1.41 to 0.27 ns 
  Social support 0.17 -0.69 to 1.03 ns 
  School status -0.93 -1.77 to -0.09 * 
  Health perception -1.69 -2.64 to -0.74 * 
 KINDL Emotional wellbeing -0.44 -1.07 to 0.19 ns 
   Compared to  
AMD 
 QOL Scale for Meta-
bolic Disease 
Impact of IEM -0.24 -1.18 to 0.69 ns 
 Attention -0.64 -1.43 to 0.16 ns 
 Self-esteem about IEM -0.45 -1.26 to 0.36 ns 
  Physical function -1.14 -1.96 to -0.33 * 
  Labeling -0.15 -1.02 to 0.71 ns 
  Social support -0.55 -1.47 to 0.38 ns 
  School status -1.41 -2.41 to -0.40 * 
  Health perception -1.67 -2.70 to -0.64 * 
 KINDL Emotional wellbeing -0.20 -0.88 to 0.48 ns 
   Compared to  
population norms 
 QOL Scale for Meta-
bolic Disease 
 n.a. n.a. to n.a. n.a. 
       
 KINDL  n.a. n.a. to n.a. n.a. 
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Table 3: Continuous outcomes in the reviewed studies (continued) 
   Compared to  
healthy population norms 
Packman et al., 2007 PedsQL proxy-report Physical function -1.14 -1.54 to -0.74 * 
N = 55  Emotional function -1.19 -1.59 to -0.80 * 
  Social function -1.48 -1.88 to -1.08 * 
  School function -1.46 -1.86 to -1.06 * 
  Psychosocial -1.66 -2.06 to -1.26 * 
  Total  -1.65 -2.05 to -1.25 * 
   Compared to  
cancer population norms 
  Physical function -0.06 -0.46 to 0.34 ns 
  Emotional function -0.23 -0.63 to 0.17 ns 
  Social function -0.65 -1.05 to -0.25 * 
  School function -0.39 -0.80 to 0.01 ns 
  Psychosocial -0.54 -0.94 to -0.14 * 
  Total  -0.40 -0.80 to 0.00 ns 
        
Psychological adjustment and adaptive functioning: self-report 
   Compared to  
population norms 
Muelly et al., 2013 BDI / BYI BDI score adults 0.54 -0.02 to 1.11 ns 
N = 26  BYI T-score -0.44 -1.01 to 0.12 ns 
  Combined z-score 0.19 -0.36 to 0.75 ns 
 BAI / BYI BAI score adults 0.38 -0.18 to 0.94 ns 
  BYI T-score -0.28 -0.83 to 0.28 ns 
  Combined z-score 0.13 -0.43 to 0.68 ns 
   Compared to  
population norms 
Mazariegos et al., 
2012 Vineland or ABAS Total -1.09 -1.46 to -0.72 * 
N = 31        
Psychological adjustment and adaptive functioning: proxy-report 
   Compared to  
population norms 
Beauchamp et al., 
2009 CBCL Internalising problems -0.32 -1.31 to 0.66 ns 
N = 4  Externalising problems -0.76 -1.74 to 0.23 ns 
  Total  -1.32 -2.31 to -0.34 * 
 ABAS General score -0.23 -1.21 to 0.75 ns 
  Conceptual -0.65 -1.63 to 0.34 ns 
  Social 0.84 -0.14 to 1.82 ns 
  Practical -0.50 -1.48 to 0.48 ns 
   Neonatal onset  
vs. population norms 
Krivitzky et al., 2009 ABAS, age < 3 y General score -0.35 -0.83 to 0.13 ns 
N = 92 ABAS, age 3-16y General score -2.09 -2.64 to -1.53 * 
   Late onset  
vs. population norms 
 ABAS, age < 3 y General score -0.67 -1.42 to 0.07 ns 
 ABAS, age 3-16y General score -0.76 -1.04 to -0.47 * 
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Table 3: Continuous outcomes in the reviewed studies (continued) 
   Hyp.amm. events >= 0  
vs. population norms 
 ABAS, age < 3 y General score -0.37 -0.88 to -0.37 * 
 ABAS, age 3-16y General score -1.00 -1.33 to -0.99 * 
   Hyp.amm. events = 0  
vs. population norms 
 ABAS, age < 3 y General score -0.55 -1.20 to 0.11 ns 
 ABAS, age 3-16y General score -0.96 -1.36 to -0.56 * 
   Compared to  
population norms 
Packman et al., 2007 BASC parent-report Hyperactivity 0.26 -0.03 to 0.55 ns 
N = 55  Aggression 0.24 -0.04 to 0.53 ns 
  Conduct problems 0.03 -0.25 to 0.32 ns 
  Anxiety 0.05 -0.24 to 0.34 ns 
  Depression 0.08 -0.21 to 0.36 ns 
  Somatization 0.21 -0.08 to 0.50 ns 
  Atypicality 0.30 0.01 to 0.59 * 
  Withdrawal 0.04 -0.24 to 0.33 ns 
  Attention problems 0.68 0.39 to 0.97 * 
  Externalising problems 0.21 -0.08 to 0.50 ns 
  Internalising problems 0.14 -0.15 to 0.43 ns 
  Behavioral sympt. index 0.37 0.08 to 0.66 * 
  Adaptive skills -0.59 -0.88 to -0.30 * 
   Compared to  
population norms 
 BASC teacher-report Hyperactivity 0.41 0.07 to 0.76 * 
  Aggression 0.28 -0.07 to 0.62 ns 
  Conduct problems -0.18 -0.52 to 0.16 ns 
  Anxiety 0.55 0.20 to 0.89 * 
  Depression 0.11 -0.23 to 0.45 ns 
  Somatization 0.66 0.32 to 1.01 * 
  Attention problems 0.75 0.41 to 1.10 * 
  Learning problems 0.74 0.39 to 1.08 * 
  Atypicality 0.68 0.34 to 1.03 * 
  Withdrawal 0.19 -0.15 to 0.53 ns 
  Externalising problems 0.23 -0.12 to 0.57 ns 
  Internalising problems 0.56 0.21 to 0.90 * 
  School problems 0.76 0.42 to 1.11 * 
  Behavioral sympt. index 0.62 0.28 to 0.97 * 
  Adaptive Skills -0.36 -0.71 to -0.02 * 
   Compared to  
population norms 
Pohorecka et al., 2012 CBCL Internalising problems 1.14 0.44 to 1.84 * 
N = 8  Externalising problems 0.77 0.08 to 1.47 * 
  Withdrawn 1.30 0.60 to 2.01 * 
  Somatic complaints 1.19 0.49 to 1.90 * 
  Anxious depressed 0.62 -0.08 to 1.32 ns 
  Social problems 1.52 0.82 to 2.23 * 
  Thought problems 0.89 0.19 to 1.59 * 
  Attention problems 1.15 0.45 to 1.86 * 
  
41   –    Empirical research    
 
Table 3: Continuous outcomes in the reviewed studies (continued) 
  Rule breaking behavi-
our 1.07 0.37 to 1.77 * 
  Aggressive behaviour 0.86 0.16 to 1.56 * 
   Compared to  
population norms 
Simons et al., 2006 CBCL Internalising problems 0.79 -0.02 to 1.59 ns 
N = 11  Externalising problems 0.36 -0.44 to 1.17 ns 
    Total 0.64 -0.17 to 1.44 ns 
1A positive value means that the IT-IEM group scored higher than the control group. A negative value means that 
the IT-IEM group group lower than the control group. Higher values are favourable in all scales except for the 
BASC (Packman et al.) where high scores mean more problems (exception: BASC subscale adaptive skills).  
Abbreviations: ABAS (Adaptive Behaviour Assessment System), BAI (Beck Anxiety Inventory), BASC (Behav-
iour Assessment System for Children), BDI (Beck Depression Inventory), BYI (Beck Youth Inventory), CBCL 
(Child Behaviour Check List), KINDL (Revised questionnaire to assess health-related quality of life in children and 
adolescents), PedsQL (Pediatric Quality of Life Inventory), Vineland (Vineland Adaptive Behavior Scale), 
WHOQOL-100 (World Health Organization Quality of Life assessment) 
 
Self- vs. proxy-report  
One study (Packman et al., 2007) compared self- and parent proxy-ratings. The authors 
reported significantly better scores in self-reported HrQoL for the domains of physical, emo-
tional and social HrQoL, but no difference for school functioning.  
 
Risk factors 
No risk factors regarding HrQoL were investigated in the studies.  
 
Findings on psychological adjustment and adaptive functioning 
Self-report 
Results for self-reported psychological adjustment and adaptive functioning are shown 
in Tables 3 and 4. Depression and anxiety (both current and lifetime) were reported to be 
more prevalent in a group of IT-IEM patients than in a healthy group (Muelly et al., 2013). 
However, the study revealed no differences between IT-IEM patients and population norms 
regarding anxiety and depression symptom severity. Another research group found adaptive 
functioning for IT-IEM patients to be significantly lower than in a norm population 
(Mazariegos et al., 2012).  
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Proxy-report 
All studies used parent proxy-reports and one additionally used teacher proxy-reports 
(Tables 3 and 4). Proxy-report findings on different aspects of psychological adjustment and 
adaptive functioning mostly showed either no difference or worse adjustment and more prob-
lems for IT-IEM patients than norms (Grünert et al., 2013; Krivitzky et al., 2009; Packman 
et al., 2007; Pohorecka et al., 2012; Simons et al., 2006). Fewer problems compared to pop-
ulation norms were described in one paper (Beauchamp et al., 2009). 
Proxy-parent vs. proxy-teacher-report 
According to one study, teachers reported more internalising problems (somatisation, 
anxiety) than parents (Packman et al., 2007). 
 
Risk factors 
For psychological adjustment and adaptive functioning parameters, several risk factors 
were investigated. The risk for lifetime anxiety or lifetime depression disorders was higher 
in patients who were encephalopathic at diagnosis than patients who were non-symptomatic 
at diagnosis (Muelly et al., 2013). Adaptive functioning correlated with IQ according to an-
other study, but no correlation was found between adaptive functioning and age at diagnosis, 
number of preceding metabolic crises, or number of hospitalisations (Mazariegos et al., 
2012). Finally, lower scores in adaptive functioning were found among patients with neonatal 
onset than among late-onset patients, but no difference was found in the number of hyperam-
monemic events (Krivitzky et al., 2009) 
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Table 4: Dichotomous outcomes in the reviewed studies 
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Table 4: Dichotomous outcomes in the reviewed studies (continued) 
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1.5. Discussion 
HrQoL, psychological adjustment, and adaptive functioning 
The first aim of our systematic review was to explore the current state of research on 
HrQoL, psychological adjustment, and adaptive functioning in patients with IT-IEM. We 
found 11 articles reporting HrQoL, psychological adjustment, or adaptive functioning for this 
group of patients. Results for HrQoL varied across studies from lower HrQoL to similar and 
better scores for IT-IEM patients compared to norms. Notably, proxy-ratings of patients’ 
HrQoL were consistently similar or lower than norms. Results for psychological adjustment 
and adaptive functioning varied less and were mostly comparable to norms or showed worse 
adjustment for IT-IEM patients. Fewer problems were only reported once (Beauchamp et al., 
2009) – however, this result has to be considered with care. The sample size of this study was 
very small (n = 4) compared to the other studies, and the authors themselves expressed some 
doubts about the reliability of their results.  
Impaired HrQoL, psychological adjustment, or adaptive functioning can have different 
causes. Firstly, this may be a result of the distress experienced in IT-IEM, such as fear of 
metabolic crises or social problems associated with the diet (Weber et al., 2012). Secondly, 
neurological sequelae of IT-IEM can lead directly to cognitive or psychological problems 
and thus to worse psychological adjustment and adaptive functioning in everyday life  (e.g. 
psychotic or depressive symptoms through CNS damage) (Walterfang et al., 2013). Thirdly, 
it is important to consider the interaction between HrQoL and psychological adjustment, 
since the literature shows impaired HrQoL in patients with mental disorders (Dey et al., 
2012). Therefore, impaired HrQoL may be caused by mental health problems. In contrast, 
good HrQoL in IT-IEM patients may be explained by the theory of response shift (Sprangers 
& Schwartz, 1999). This would account for the often-seen improvement of HrQoL in chron-
ically ill patients as a result of an accommodation process which involves changing internal 
standards, values and conceptualisation. According to Sprangers and Schwartz (Sprangers & 
Schwartz, 1999), a response shift results from the interaction of different variables: health 
status, mechanisms such as coping, and antecedents such as personality or sociodemo-
graphics.  
Interestingly, HrQoL was more often reported to be impaired when rated by parents 
compared to self-ratings by patients. In line with this, a comparison of self- and proxy-ratings 
revealed better self-ratings in most domains (Packman et al., 2007). The fact that HrQoL of 
children with chronic health conditions is rated lower by parents than by the children them-
selves is well known from the literature (Upton et al., 2008). Furthermore, there is a close 
relation between the parent’s rating of a child’s HrQoL and the parent’s own HrQoL (Eiser 
& Varni, 2013): Parents experiencing low HrQoL rate their child’s HrQoL low as well. This 
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might be especially relevant in parents of children with IT-IEM, since these diseases demand 
intensive care and may have a great impact on the lives of caregivers (Hatzmann et al., 2009). 
Another explanation for the lower proxy-ratings may be the ability of parents to anticipate 
the future problems of the child. Young children in particular may not be aware of these to 
the same extent. 
A major reason for the inconsistent findings may be attributed to methodological is-
sues. Most of the HrQoL instruments were not specifically tailored to patients with IT-IEM. 
One study used an invalidated disease-specific instrument (Eminoglu et al., 2013). In addi-
tion, the HrQoL of IT-IEM patients was compared to different groups: population norms or 
other metabolic diseases. Sample sizes were often small, a state of affairs that is often found 
in paediatric research and especially in research in the field of rare diseases. Statistically, 
such small sample sizes make it more difficult to detect group differences. In addition, one 
study had a clear selection bias by only including patients who were cognitively able to an-
swer questionnaires (Grünert et al., 2013). Another significant limitation is the choice of in-
formants; most studies used proxy-reports which do not fully reflect self-reports of the 
patients. It is clear from the literature that these two kinds of reports are not interchangeable 
(Eiser & Varni, 2013).  
 
Risk factors for HrQoL, psychological adjustment, and adaptive functioning 
The second aim of this review was to detect risk factors for HrQoL, psychological ad-
justment, and adaptive functioning for IT-IEM patients. Only a few risk factors for psycho-
logical adjustment and adaptive functioning have been investigated so far, and none have 
been examined for HrQoL. The risk factors examined were mainly medical (Krivitzky et al., 
2009; Mazariegos et al., 2012; Muelly et al., 2013). With regard to cognitive parameters, IQ 
was investigated in one study (Mazariegos et al., 2012). Two studies revealed that metabolic 
events in the neonatal period were associated with psychosocial adjustment: patients diag-
nosed as encephalopathic newborns had a higher risk of suffering from anxiety or depression 
during their lifetime than patients who were metabolically stable during the newborn period 
(Muelly et al., 2013). Adaptive functioning scores were lower for neonatal-onset than for 
late-onset patients (Krivitzky et al., 2009). Similar results have been found before and may 
be explained by the fact that crises have a negative impact on the developing brain, especially 
in highly vulnerable newborns (Landolt, Nuoffer, Steinmann, & Superti-Furga, 2002; Muelly 
et al., 2013).  
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Strengths and limitations of this review 
This systematic review was conducted in accordance to the PRISMA guidelines (Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analysis) (Moher, Liberati, 
Tetzlaff, & Altman, 2009). In order to find as many eligible studies as possible, we applied 
several search strategies: we searched different databases and did not restrict the search to 
English articles. Additionally, we tried to find additional and / or unpublished studies by 
reference screening and contacting experts in the field. Study selection and data extraction 
were conducted independently by two reviewers, thereby diminishing the risk of bias. The 
main weakness of our review is the inability to pool results from the different studies. The 
different study designs and assessment methods did not permit such meta-analytic calcula-
tions. Nevertheless, better comparability of the results was attained by indicating effect sizes 
and their CI. Another limitation of this systematic review can be found in our comparison of 
studies with very different sample sizes (ranging from N = 4 to N = 92), the reason why the 
calculated effect sizes have to be interpreted carefully. Because the incidence rates of rare 
diseases are small and because there is only a very limited number of studies that could be 
included in our review, we decided not to exclude studies with small sample sizes (inclusion 
criterion N > 1). To account for this limitation, we considered sample sizes in the calculation 
of effect sizes by correcting mechanisms. The different sizes were also taken into account by 
computing CIs of effect sizes.  
 
Suggestions for future research 
Based on the findings of this review, several implications can be drawn. Firstly, HrQoL 
should be considered as an essential outcome parameter in future clinical trials. Up to now, 
treatment evaluations of patients with IT-IEM have predominantly focused on medical out-
comes. However, because survival rates have increased considerably, improvement of 
HrQoL for patients with IT-IEM must be an additional major goal of new treatments.  
Secondly, it is important to increase the methodological quality of psychosocial re-
search among IT-IEM patients. Multicentre studies are necessary both to avoid convenience 
sampling with a high risk for biased data and to increase sample sizes. International patient 
registries (e.g. E-IMD, www.e-imd.com) can help to achieve this goal and to aggregate 
knowledge. This review has shown that a variety of assessment instruments is currently in 
use, thus complicating the pooling of results. Most of the studies used generic, non-disease-
specific instruments. Only one of the reviewed studies used a disease-specific scale 
(Eminoglu et al., 2013); however, this was not validated. Generic instruments have the ad-
vantage that results can usually be compared to a healthy population or a population with 
Empirical research   –    48 
 
another disease (J. S. Cohen & Biesecker, 2010). However, they do not assess the specific 
problems of medical conditions. In contrast, disease-specific HrQoL scales are related to the 
distinct effects of a particular disease (Walterfang et al., 2013). They are more sensitive for 
special topics that are of interest and more meaningful for specific groups of patients. The 
use of disease-specific HrQoL assessment measures in clinical trials has been shown to be 
valuable in other severe medical conditions (Walterfang et al., 2013). To date, no validated, 
disease-specific measure is available for patients with IT-IEM. Furthermore, from a method-
ological viewpoint, it is desirable to consider different informants; because proxy-reports 
have several limitations, the patients’ well-being should also be assessed using self-ratings.  
Thirdly, knowledge of risk factors influencing HrQoL, psychological adjustment, and 
adaptive functioning is of great importance. Very few studies have addressed this topic at all, 
and where they did, research was restricted to medical or biochemical parameters or IQ. 
Medical parameters are weak predictors for HrQoL in most chronic diseases (Walterfang et 
al., 2013). In contrast, a systematic review exploring HrQoL in rare genetic conditions has 
emphasised that parameters explaining how patients coped with their disease were good pre-
dictors of HrQoL (Walterfang et al., 2013). As an example, the authors mentioned scales 
such as “acceptance of disability” or “sense of coherence”, which were positive predictors 
for QoL, while feeling hopeless or having a fatalistic view correlated with lower QoL 
(Walterfang et al., 2013). Other predictors for HrQoL in chronic disease described in the 
literature include concepts such as locus of control, attachment, or well-being of the parents 
(Agostini et al., 2014; Dulfer et al., 2014; Fan, Eiser, Ho, & Lin, 2013). In IT-IEM patients, 
such individual and familial psychosocial risk factors have not yet been studied. Current re-
search is, unfortunately, still focused on a fully biomedical model, instead of including the 
promising psychosocial perspective (Walterfang et al., 2013).  
 
Clinical implications 
The small number of studies, partially inconsistent results, and the few risk factors ad-
dressed make it difficult to draw implications for clinical practice. Since HrQoL, psycholog-
ical adjustment, and adaptive functioning seem to be impaired in some patients, we suggest 
offering psychological support for patients and their families to help them cope more effec-
tively with the disease. Knowing more about risk factors would allow the development of 
targeted interventions for certain groups of patients. Overall, we consider it important to sup-
port patients and their families with a comprehensive care model, including psychological 
and social interventions to complement the medical ones (De Ridder et al., 2008; Simons et 
al., 2006). 
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Conclusion 
Research data on psychosocial factors in IT-IEM patients are generally sparse. How-
ever, the growing interest in the topic is underlined by the fact that seven of the 11 articles 
reviewed were published in 2012 or 2013. Further research and improved methodological 
quality of studies are required. Multicentre studies and the use of a standardised, disease-
specific assessment tools are needed to establish HrQoL as an important additional outcome 
parameter in patient-centred research and clinical trials.  
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tive analysis of interviews with paediatric patients and their parents 
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2.1. Abstract  
 Introduction: Progress in diagnosis and treatment of patients with intoxication-type in-
born errors of metabolism (IT-IEM) such as urea cycle disorders, organic acidurias, or maple 
syrup urine disease is resulting in a growing number of long-term survivors. Consequently, 
health-related quality of life (HrQoL) of patients is increasingly regarded as a meaningful 
outcome parameter. To develop the first validated, disease-specific HrQoL questionnaire for 
IT-IEM, patients and parents were interviewed as content experts to identify major physical 
and psychosocial constraints and resources.  
Methods: Focus group interviews with 19 paediatric IT-IEM patients and 26 parents 
were conducted in four metabolic centres in Austria, Germany, and Switzerland. Disease-
specific HrQoL categories were established by qualitative content analysis 
Results: Fourteen disease-specific topics related to the three well-established generic 
HrQoL dimensions of physical, mental, and social functioning were derived from the inter-
view transcripts. Both patients and parents perceived dietary restrictions and social stigmati-
zation as major burdens. Dietary restrictions and emotional burdens were more important for 
young (<8 years) patients, whereas cognition, fatigue and social issues were more relevant to 
older patients (≥8 years). Treatment-related topics had a significant effect on social and emo-
tional HrQoL.  
Discussion: By exploring patients’ and parents’ perspectives, 14 HrQoL categories 
were identified. These new categories will allow the development of a disease-specific, stand-
ardized questionnaire to assess HrQoL in paediatric IT-IEM patients. Age-appropriate infor-
mation on the disease and psychosocial support targeted to patients’ individual burdens are 
essential to the delivery of personalized care that takes account of physical, mental, and social 
dimensions of HrQoL. 
51   –    Empirical research    
 
1 sentence take-home message: Taking patients’ and parents’ perspectives into account 
allows the definition of meaningful follow-up parameters and the development of personal-
ized interventions. 
 
2.2. Introduction 
Urea cycle disorders (UCD), organic acidurias (OA) and maple syrup urine disease 
(MSUD) are intoxication-type inborn errors of metabolism (IT-IEM) sharing main clinical 
and treatment characteristics. Patients must follow a low-protein diet, have to cope with the 
constant fear of life-threatening metabolic crises, and frequently develop neurocognitive im-
pairments.  
Considerable progress in recent decades in the diagnosis and treatment of IT-IEM has 
resulted in a growing number of long-term survivors (Batshaw et al., 2014; De Baulny et al., 
2005). The long-term medical care and support of patients and families requires insight into 
subjective psychosocial conditions and health-related quality of life (HrQoL) (Bullinger, 
2002). HrQoL is a multidimensional construct that represents “a patient’s perception of the 
impact of disease and treatment on functioning in a variety of dimensions, including physical, 
psychological and social domains” (Varni et al. 1999, p. 126). As such, it is a meaningful 
outcome parameter for clinical trials and the evaluation of the quality and cost-effectiveness 
of treatment (Bullinger, 2002). Three general types of HrQoL assessment measures exist. 
Generic HrQoL instruments (e.g. the PedsQL (Varni et al., 1999)) compare HrQoL between 
healthy individuals and patients, chronic generic instruments (e.g. DISABKIDS (The 
DISABKIDS Group Europe, 2006)) serve to assess and compare HrQoL in patients with 
chronic diseases in general, and disease-specific instruments (e.g. the PKU-QOL (Regnault 
et al., 2015)) address the characteristics of a particular disease or disease group. The latter 
are therefore the method of choice in clinical trials (Walterfang et al., 2013). Since the con-
cept of HrQoL is based on subjective experience, self-assessment using age-appropriate in-
struments is the gold standard (Matza et al., 2013). Self- and proxy-reports are not 
interchangeable (Upton et al., 2008); but proxy-reports are valuable in very young or cogni-
tively impaired patients.  
Although interest in psychosocial issues in IT-IEM has recently increased, research is 
still sparse and has methodological shortcomings (Zeltner et al., 2014). The first disease-
specific assessment instrument for individuals with IT-IEM is currently under development 
by our research group. In this process, patients and parents are involved as “content experts” 
(Matza, Swensen, Flood, Secnik, & Leidy, 2004). Focus group interviews are the method of 
choice to identify topics, concerns and resources relevant in everyday life (Matza et al., 
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2013). This paper presents the qualitative content analysis of focus group and single inter-
views with IT-IEM patients and their parents. The two main aims of this study were (1) to 
identify HrQoL topics relevant for paediatric IT-IEM patients and (2) to investigate differ-
ences in statement frequencies of topics related to the informant (patient or parent) and to the 
age of the affected child.  
 
2.3. Methods 
Subject recruitment 
Physicians from four metabolic centres in Austria, Germany, and Switzerland invited 
IT-IEM patients (≤18 years) and their parents by phone or during routine consultations for 
participation. If patients were younger than 8 years or unable to participate due to neurocog-
nitive impairment, only their parents were invited.  
 
Focus groups and single interviews 
Focus group interviews were conducted by a team of trained moderators with medical 
or psychological background in each centre. For patients and parents unable to attend, single 
interviews were arranged either in the hospital, by phone, or at home. Focus groups of 2-7 
participants were composed based on patient’s age (<8 years, 8-12 years, 13-18 years). Pa-
tients younger than 8 years were represented by their parents. Parallel patients’ and parents’ 
focus groups were conducted for 8-12 and 13-18 year olds. Each group was led by two trained 
moderators, who followed a manual specifically adapted for IT-IEM and based on the 
DISABKIDS methodology (The DISABKIDS Group Europe, 2006). Single interviews were 
conducted by one moderator following the manual. The focus group procedure is presented 
diagrammatically in Figure 6.  
 
Data processing and analysis 
Interviews were transcribed verbatim in German from audio recordings using transcrip-
tion software (f4, 2014, Dr. Dresing & Pehl GmbH, Marburg, Germany). Statements used in 
the result section of this paper were translated to English by a professional interpreter. Two 
coders (N.A.Z., S.L.) analyzed the interviews according to the established qualitative data-
analysis procedure developed by Mayring (Kuckartz, 2014; Mayring, 2010) using the 
MAXQDA software (MAXQDA, version 11, 1989-2015, VERBI Software – Consult – Sozi-
alforschung GmbH, Berlin, Germany).  
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Statements identified in the transcripts were assigned to the three HrQoL core dimen-
sions physical, mental and social HrQoL (World Health Organisation, 1948). Based on these 
core dimensions, categories were inductively defined. The system of categories was elabo-
rated in several analytical cycles (Figure 7). Coding disagreements were resolved by discus-
sion. Two psychologists not otherwise involved in the study assigned 42 randomly chosen 
statements to the 14 categories. Inter-rater reliability (J. Cohen, 1988) was “almost perfect” 
for one (Cohen’s kappa = 0.94) and “substantial” for the second rater (Cohen’s kappa = 0.79) 
(Landis & Koch, 1977).  
 
 
*Part 2 was omitted in single telephone interviews.  
**Discussion among participants was encouraged during the interview. Change in order of the topics was thereby tolerated. 
Moderators made sure that all topics were addressed. 
 
Figure 7: Content of interviews 
Based on the developed manual and content analysis based on Mayring an Kuckartz (Kuckartz, 2014; 
Mayring, 2010) 
 
Educational status of parents was assessed using the ISCED Manual (OECD, 1999) 
which differentiates seven internationally comparable levels. Sex distribution among age 
groups was examined by fisher’s exact tests. Chi square tests and standardized residuals were 
used to detect differences of statement frequencies per category between informant groups 
(patients / parents) and patients’ age groups. Issues mentioned repeatedly by single partici-
pants resulted in multiple coded statements; length of statements was not considered. Step-
wise comparisons were calculated between core dimensions, grouped categories and single 
categories (see Table 6). Analyses were performed using the statistical software package 
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SPSS, version 20.0 for Windows (SPSS Inc., Chicago, IL, USA). Statistical significance was 
defined as p < 0.05.  
 
2.4. Results 
Sample characteristics 
Thirty (71%) of 42 invited families participated, resulting in a study sample of 19 chil-
dren and adolescents (n = 9 females, n = 10 males; n = 9 OA, n = 9 UCD, n = 1 MSUD; age 
range 9.5 to 16.5 years, mean = 13.0 ± 2.3 years) and 26 parents (n = 25 mothers, n = 1 
father). All parents had at least one child affected by IT-IEM (n = 12 females, n = 16 males 
(from which n = 2 siblings); n = 18 OA, n = 8 UCD; patients’ age range 0.9 to 16.8 years, 
mean = 10.3 ± 4.7 years) (see Table 5). Educational status of parents (mean of fathers and 
mothers educational status) was mean = 3.64 (± 1.12, range 2-6). Distribution of patients’ 
sex among age groups did not significantly differ for patients (p = 0.18) or parents (p = 0.09). 
 
Categorical system 
A total of 915 statements addressing patients’ HrQoL were identified from 19 tran-
scripts of 5 patient and 6 parent focus groups and 5 patient and 3 parent single interviews. 
Fourteen content categories were defined and allocated to one of the core dimensions (phys-
ical, mental and social HrQoL) (Table 6). Frequencies of statements per category for patients 
and parents are shown in Figure 8. 
 
Physical dimension of HrQoL 
Symptoms and treatment of the disease relate to the physical dimension of HrQoL. 
Dietary restrictions (intake of regular food and special low-protein food) were a main topic 
for both patients and parents (Figure 8). However, attitudes varied widely from “being used 
to dietary restrictions” or even having an “aversion to proteins” to complaints about “missing 
forbidden food and freedom of food choice” and “required organisational effort”. The latter 
were especially encountered in social situations such as barbecues or school camps. A 16-
year-old girl commented: “When I go to school camp, I have to take a second suitcase along. 
It’s all food. And a woman cooks especially for me”. 
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Table 5: Number of interview participants in focus groups and single interviews 
  Patient’s age   
 <8 years 8-12 years 13-18 years 
All age 
groups 
N patients - 9 10 19 
N parents 9 9 8 26 
N patients in focus group interviews - 6 8 14 
N patients in single interviews - 3 2 5 
N parents in focus group interviews 8 8 7 23 
N parents in single interviews 1 1 1 3 
Total participants 9 18 18 45 
 
According to parents, pre-schoolers did not experience diet as particularly burdensome. 
In contrast, parents experienced caring for a young child’s diet as most difficult and stressful. 
They felt disburdened when their child was able to take over responsibility by self-monitoring 
or indicating need for their sick-day regimen. The mother of a 5-year-old girl stated: “When 
she was two or three years old, she would often snatch a piece of sausage and put it into her 
mouth (…). By now I know that she won’t do this anymore, that’s something I can rely on”. 
However, diet places an incessant strain on family life. Parents felt children used food intake 
or vomiting to exert pressure or gain attention, as explained by the mother of a 16-year-old: 
“That’s always some form of pressure of hers, although she often isn’t able to express herself 
that well; but with food she’s totally in control of me and that she knows very well”. Against 
this background, parents considered tube feeding supportive, since arguing about food intake 
became less central: “As soon as he had received the PEG, we were happy. We were no 
longer at the hospital, the pressure on me was gone, I was no longer under pressure” (Mother 
of a 13-year-old). In contrast, patients may hide their tube: “Absolutely nobody is allowed to 
see it [the tube] (…) and nobody is allowed to know about it, except close relatives and 
friends” (Mother of a 10-year-old). 
Although intake of dietetics and medication was daily routine, the unpleasant taste of 
amino-acid mixtures remained a major issue and patients preferred pills over drinks when-
ever possible. Moreover, the lack of flexibility allowed by a tightly scheduled intake of med-
ication and supplement interfered with everyday life and spontaneous engagement in social 
Empirical research   –    56 
 
situations. Side-effects such as diarrhoea or body odour, namely the fishy odour of carnitine, 
were additional constraints in social situations. 
The majority of patients felt blood sampling (category routine controls / hospital) to 
be extremely stressful and commented more frequently on this subject than parents (not sta-
tistically significant). Adolescents coped better with blood sampling but complained that hos-
pital appointments reduced their leisure time. 
Motor deficits and limitations in keeping up with peers were the most burdensome lim-
itations for children with IT-IEM. One of the fondest wishes expressed by non-ambulatory 
children young than 8 years was “being able to walk and run like others”. Fatigue / nausea / 
vomiting were especially important for older patients comparing their performance with 
healthy peers’. „Because when I overdo it, I have to throw up. I simply don’t manage as much 
as all the others” (16-year-old male patient working as apprentice).  
Metabolic crises were traumatizing experiences and caused constant fear of potential 
new crises, infections and other triggers. Most patients had experienced metabolic crises dur-
ing infancy, and it was mainly their parents who remembered the details, as the father of a 7-
year-old stated: “We had five crises with him, ended up five times in intensive care. Once we 
were abroad and the physicians said: You know, we can’t do anything, the boy will die”. The 
mother of a 16-year-old said: “Gastro-intestinal flu: all alarm bells ring, (…) this is a one-
way ticket to hospital”. Parents and patients reported always planning their annual leave in 
proximity to metabolic hospitals they trust to avoid encountering medical staff unfamiliar 
with the disease.  
Comparing frequencies of statements  
The frequency distribution of patients’ and parents’ statements significantly differed 
among the categories associated with treatment (χ2 (3) = 25.24, p < 0.05). Patients mentioned 
tube feeding significantly less frequently than parents. 
Comparison of patients’ reports revealed a significant age difference between symptom 
and treatment statements (χ² (2) = 11.44, p < 0.05). Eight- to 12-year-old patients made more 
statements about treatment, while 13-18 year olds talked more frequently about symptoms 
and limitations. Comparing categories describing symptoms revealed that, in contrast to par-
ents of older children, parents of patients younger than 8 years made no statements related to 
fatigue / nausea / vomiting (χ2 (4)= 15.18, p < 0.05). In the categories describing treatment, 
parents of younger children talked more frequently about dietary restrictions and less fre-
quently about medication / dietetics than parents of older children and adolescents (χ2 (6) = 
22.19, p < 0.05). 
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All other comparisons in the physical dimension between different age and respondent 
groups were not significant. 
 
Table 6: System of disease-specific HrQoL categories based on the content of the interviews 
Dimension Category  Group Description of category 
Physical Metabolic crises /  
anticipation of crises 
 
Sy
m
pt
om
s 
Experiencing metabolic crises, anticipation of cri-
ses (i.e. infections, hygiene), emergency admis-
sions because of crisis 
 
 
 Physical limitations 
 
Motor limitations, organ problems 
 Fatigue / nausea /  
vomiting 
 Fatigue, nausea and vomiting (events not imme-
diately connected to metabolic crisis and emer-
gency admissions) 
 
 
 Dietary restrictions 
 
Tr
ea
tm
en
t 
Dietary restrictions, regular food intake, low-pro-
tein food 
 
 
 Medication / dietetics 
 
Drug and dietetics intake, side effects 
 Tube feeding  PEG tube, nasogastric tube 
 Routine controls /  
hospital 
 
Routine controls in the hospital / by the physi-
cian, reactions to blood sampling 
 
 
Mental Negative emotions 
 
Em
ot
io
ns
 
Statements with negative emotional content. 
Sadness, anger, crying, feeling different than 
friends, shame (not wanting to make the condi-
tion public), wanting the disease gone 
 
 
 Positive emotions 
 Statements with positive emotional content. Be-
ing happy, satisfied, feeling good and "normal" 
with the condition 
 
 
 Cognitive functioning 
  Cognitive functioning, especially in school, dis-
turbed concentration, mental disability 
 Independent living   Feeling restricted in conduct of life, choice of 
employment, planning of leisure time 
Social Friends 
 
So
ci
al
 li
fe
,  
so
ci
al
 s
up
po
rt Having friends, social support / social inclusion 
by friends 
 
 
 Family 
 Statements concerning the family (parents, sib-
lings, grandparents, uncles, aunts…) and their 
handling of the condition 
 
 
 Stigmatization /  
exclusion 
  Being treated differently (negative / positive) by 
peers and society based on the condition: teas-
ing, interrogation regarding condition, being pit-
ied, exclusion (i.e. difficulties finding a school, 
going on school excursions) 
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Mental dimension of HrQoL 
The mental dimension encompasses statements related to emotions, cognition and is-
sues of independent living. Negative emotions were predominantly reported. The most fre-
quent “fondest wish” of the patients was “not to have the disease” or to be “more like normal 
kids”. The perception of not being able “to do what other kids do” caused frustration. The 
impression of being “different” in some cases led to feelings of shame, making patients 
averse to others being informed about their condition. Since having a meal together is of high 
social significance, IT-IEM patients often felt socially excluded. The mother of a 7-year-old 
reported: „The kids [at Kindergarten] were not allowed to share [food] with him. This trou-
bled him a lot, the fact that he now suddenly did not belong to the group. He cried bitterly 
then”.  
 
 
Figure 8: Percentage of statements from total statements per category, for each patient and parent interviews 
(both for patients aged from 8 to 18 years) 
 
Cognitive functioning and school performance gained increasing significance for older 
children and adolescents. Children attending regular schools felt inferior when comparing 
their school performance with those of their healthy peers. Parents of children with severe 
cognitive impairment attending special schools worried about their children’s performance 
but had the impression that the children themselves did not. 
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Comparing frequencies of statements 
Parents’ statements regarding emotions, cognitive functioning and independent living 
significantly differed between age groups (χ² (2) = 29.70, p < 0.05). In the younger age groups 
more statements addressed emotions, while cognitive functioning was more important to the 
13-18 years group.  
All other comparisons in the mental dimension were not significant. 
 
Social dimensions of HrQoL 
The social dimension refers to the impact of the disease on social life and stigmatization 
experiences. Patients and parents generally felt supported by family and close friends. The 
second highest number of statements was attributed to the social stigmatization / exclusion 
category (Figure 8).  
Peers teased patients because of physical or cognitive limitations or side effects of med-
ication. A 9-year-old boy reported: „Actually, my disease is okay, except that some kids make 
fun of it (…). The medication smells of fish, so they call me fishhead and say that I stink of 
fish”.  
Patients of all age groups considered it difficult to explain their condition in a compre-
hensible way. “Well, my problem is simply that they keep asking: Why do you have that 
thing? And I don’t know exactly what I’m supposed to answer” (10-year-old patient). Be-
cause of her strict diet, a 16-year-old girl was referred to as “the pickiest person we know” 
by her schoolmates. “I try to explain to them what it is about. But some of them just don’t 
want to understand”. Like their children, parents considered it almost impossible to explain 
the complex, rare disease to others in an understandable way. They felt frustrated because 
they perceived that their environment had no understanding of their child’s condition. Criti-
cism of or interference with parenting style (e.g. comments that mothers were “too strict” 
about diet or offers of inappropriate meals) were experienced as stressful. Attempts to avoid 
social exclusion, for instance from school camps, exerted intense stress on families (escorting 
the child; precooking meals). Finding a sensitive social environment was considered of the 
utmost importance.  
 
Comparing frequencies of statements  
Compared to 8-12 year-old patients, 13-18 year-old patients commented less on social 
life, social support (χ² (1) = 11.53, p < 0.05).  
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All other comparisons in the social dimension were not significant. 
 
2.5. Discussion 
This study explored how IT-IEM affects daily life and identified 14 categories relevant 
for patients’ HrQoL. The evolving categories could coherently be allocated to the core di-
mensions of physical, mental, and social HrQoL, resulting in a structure consistent with well-
established generic and chronic disease HrQoL questionnaires (The DISABKIDS Group 
Europe, 2006; The KIDSCREEN Group Europe, 2006; Varni et al., 1999). Categories within 
the social and emotional dimensions are similar to other questionnaires (The KIDSCREEN 
Group Europe, 2006; Vogels et al., 1999), while categories within the physical dimension 
mostly reflect disease-specific issues. Notably, other questionnaires refer to more than three 
dimensions (e.g. Varni et al. 1999), while this study kept to the three core dimensions repre-
sented in almost all HrQoL questionnaires (Rajmil et al., 2004). 
It is an important strength of this study that the individual perspectives of patients were 
considered and that the proxy-reports from parents allowed insight into perspectives of young 
and / or cognitively impaired patients. Despite international cooperation, owing to the rarity 
of the diseases, the sample size is limited and patient recruitment was not free of selection 
bias.  
Analyses of group differences demonstrated that the importance of specific HrQoL-
related topics varied depending on patients’ age and between parents and patients. Diet and 
emotional contents were predominant when patients were young (<8 years), and both patients 
and parents had to build up knowledge and routine concerning food choice and preparation 
and intake of medication and dietetics. Furthermore, hospital stays were emotionally burden-
some for young children, and families had to deal with uncertainty related to disease progres-
sion, neurocognitive development, and upcoming metabolic crises. Dealing with diet and 
uncertainty have been reported to be mayor burdens for parents with children with metabolic 
diseases before (Cederbaum et al., 2001; Pelentsov, Laws, & Esterman, 2015). As coping 
strategies significantly influence HrQoL in different chronic diseases (Graven & Grant, 
2013), tailored support may be helpful. Our results suggest that families with young children 
in particular would benefit from support targeting these uncertainties and coping with diag-
nosis and treatment. In addition, immediately at diagnosis patients should be informed about 
support groups, which have been shown to be important informational resources in rare dis-
orders (Hall, 2013; Khangura et al., 2015). Accordingly, the majority of participants in this 
study greatly appreciated the exchange with others in the context of the interviews and ex-
pressed their wish to have this opportunity more frequently. Unfortunately, research shows 
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that few families with children with rare diseases receive psychosocial support at time of 
diagnosis (Anderson et al 2013).  
In this study, cognitive functioning and feeling fatigued or less productive gained sig-
nificance for school-aged and adolescent patients, along with the increasing importance of 
school performance and social comparison with peers. Importantly, adolescents reported less 
frequently about social support than younger patients but still encountered experiences of 
stigmatization, resulting in an imbalance of constraints and resources. Our results thereby 
suggest that transitional phases (to school, to adolescence), often combined with social and 
physical challenges, deserve special attention, as this has been reported before for other in-
born errors of metabolism (Khangura et al., 2015; Packman et al., 2012). Sharing meals with 
others is known to have high social significance, hence patients living with dietary re-
strictions experience numerous potentially stigmatizing situations (Diesen, Wiig, Grut, & 
Kase, 2014). Since perceived stigmatization is a predictor for poorer psychological adjust-
ment (Masnari et al., 2013), it is of great importance that patients are supported in so called 
stigma-handling strategies (Diesen et al., 2014), such as social skills training or school-based 
interventions, in which peers are provided with basic information about the condition, result-
ing in better understanding (Sharman, Mulgrew, & Katsikitis, 2013).  
In contrast to parents, patients talked reluctantly about tube feeding. Content of state-
ments indicates tube feeding meant considerable relief for parents in terms of reduced worries 
and struggles with children about food intake. Consistent with this, previous research showed 
that tube feeding has a positive impact on parental HrQoL (Fabre et al., 2013). In contrast, 
feelings of shame and embarrassment seemed to be a reason why patients did not want to talk 
about their tube in the focus groups  – which goes along with the psychosocial impact of tube 
feeding mentioned in the literature  (Burmucic, Trabi, Deutschmann, Scheer, & Dunitz-
Scheer, 2006). We are aware of the limitation that the perspectives of very young and / or 
severely compromised patients on this issue have not been included in this study.  
Based on the results of the focus groups, two main clinical implications can be drawn. 
Firstly, patients with IT-IEM and their parents have significant need for comprehensible ex-
planations and information concerning their disease. Both patients and parents reported dif-
ficulties in making the condition understandable to the social environment. For other diseases 
(e.g. diabetes type 1), this need has been met by age-appropriate, verbal information from 
medical professionals and attractive paper- or IT-based materials (Årsand et al., 2012; 
Murphy, Wadham, Rayman, & Skinner, 2007). Improved understanding of the disease may 
motivate patients to reach better compliance (Sharman et al., 2013). Being able to explain the 
disease may help patients and parents to cope better with stigmatizing social situations such 
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as the often-experienced exclusion from school or leisure activities. In addition, low-thresh-
old access to information about IT-IEM (e.g. informative homepages, guidelines) and meta-
bolic expert advice would help physicians who are not specialized in the metabolic field in 
their communication with families.  
Secondly, beyond essential medical treatment, psychosocial care should be offered to 
IT-IEM patients and parents. It has been shown that a child’s wellbeing is considerably in-
fluenced by family variables (Landolt, Grubenmann, & Meuli, 2002), and although the inter-
views in this study focused on the wellbeing of patients, parents spontaneously reported high 
levels of distress, which require appropriate support.  
Remarkably, of the 26 participating parents only one was male. This highly unequal 
gender distribution narrows the breadth of the parent perspective but seems to reflect real-
life patterns. In many families, it is still mothers who are the primary health carer. In their 
traditional role as major income earner of the family, fathers are less present in the hospital 
setting and take other functional roles in caring for the child, such as seeking information 
(Yeh, 2004). The underrepresentation of fathers in research focusing on children with chronic 
diseases is a common fact that it is important to note (Goldstein, Akre, Belanger, & Suris, 
2013). 
Studies in other diseases clearly revealed that physicians underestimate the impact of 
disease and treatment on emotional and social domains (Srikrishna, Robinson, Cardozo, & 
Gonzalez, 2009). Treatment issues were a main concern for patients in this study because 
they hampered everyday life and made the disease perceivable for others. Thus, the fondest 
wishes of the patients to “be normal” and “not have the disease” should motivate physicians 
and dieticians to consider even more highly that the most feasible and practical treatment 
protocol serves patients and families best. Side effects of medication, such as an unpleasant 
smell, diarrhoea and frequent intake of disliked amino-acid mixtures, may impair emotional 
and social well-being more than expected. Additionally, fear of blood sampling made hospi-
tal appointments extremely stressful for many patients. It is well established that, besides 
local anaesthetics, psychological techniques (e.g. relaxation techniques, developmentally ap-
propriate distraction) are highly effective in reducing pain and anticipatory fear (Duff, 2003). 
It has been shown in other chronic paediatric diseases that addressing social issues and emo-
tional distress during regular hospital follow-ups is supportive and that the use of HrQoL 
questionnaires (Santana & Feeny, 2013) significantly increases meaningful patient-physician 
communication and patient wellbeing (Velikova et al., 2004).  
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Conclusion 
The categories identified describe HrQoL of IT-IEM patients and will allow the con-
struction of a disease-specific HrQoL questionnaire. Care for IT-IEM patients can be im-
proved by providing appropriate information about the disease and individualized 
psychosocial support to ameliorate the multifaceted effects of the disease on physical, mental 
and social wellbeing.  
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3. Development and psychometric evaluation of the MetabQoL 1.0 – a 
quality of life questionnaire for paediatric patients with intoxication-
type inborn errors of metabolism 
 
 
Reference: Zeltner, N. A., Baumgartner, M. R., Bondarenko, A., Ensenauer, R., Karall, D., 
Kölker, S., Mühlhausen, C., Scholl-Bürgi, S., Thimm, E., Quitmann, J., Burgard, P., Landolt., 
M. A., Huemer, M. (in press). Development and psychometric evaluation of the MetabQoL 
1.0 – a quality of life questionnaire for paediatric patients with intoxication-type inborn errors 
of metabolism. Journal of Inherited Metabolic Disease Reports. doi: 10.1007/8904_2017_11 
 
3.1. Abstract  
Introduction: This study is part of the “European network and registry for intoxication 
type metabolic diseases” (E-IMD) project. Intoxication-type inborn errors of metabolism (IT-
IEM) such as urea cycle disorders (UCD) and organic acidurias (OA) have a major impact 
on patients’ lives. Patients have to adhere to strict diet and medication, and may suffer from 
metabolic crises and neurocognitive impairment. Disease-specific health-related quality of 
life (HrQoL) assessment questionnaires are the method of choice to estimate the subjective 
burden of a disease. To date, no such instrument is available for IT-IEM. 
Methods: Disease-specific patient- and parent-reported HrQoL questions were con-
structed in German based on focus group interviews with patients and parents. Questionnaires 
for patients from 8-18 years were piloted with 14 participants (n = 9 children and adolescents, 
n = 5 parents) by cognitive debriefing and tested psychometrically with 80 participants (n = 
38 patients, n = 42 parents) for item characteristics, validity, and reliability to construct the 
first version of a disease-specific HrQoL questionnaire. 
Results: Twenty-eight questions were selected based on item descriptives. Scales of 
self- and proxy questionnaires demonstrated acceptable to excellent reliability in terms of 
internal consistency (Cronbach’s α = 0.70 to 0.93). Scales and total scores correlated with 
those of generic HrQoL questionnaires, showing convergent validity.  
Discussion: The MetabQoL 1.0 questionnaire exhibits sound psychometric properties 
and is a promising step towards assessing patient-reported outcomes in research and clinical 
practice. It provides a solid basis for translation into other languages and further elaboration 
and psychometric exploration in larger populations. 
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One sentence take-home message: A newly developed disease-specific health-related 
quality of life questionnaire for intoxication-type inborn errors of metabolism (MetabQoL 
1.0) allows insight into the subjective burden of disease among children and adolescents. 
 
3.2. Introduction 
This study is part of the “European network and registry for intoxication type metabolic 
diseases” (E-IMD) project, focusing on intoxication-type inborn errors of metabolism (IT-
IEM) such as urea cycle disorders (UCD) and organic acidurias (OA). Estimated incidences 
are 1:35’000 for UCD (M. L. Summar et al., 2014) and 1:21’000 for OA (Dionisi-Vici et al., 
2002). Recently, the natural course of the diseases has been described in two large samples 
(Kölker, Garcia-Cazorla, et al., 2015; Kölker, Valayannopoulos, et al., 2015; Waisbren, 
Gropman, & Batshaw, 2016). These reports highlight that IT-IEM have a major impact on 
patients’ lives: Strict diet, daily intake of medication, the permanent risk of severe metabolic 
crises, and neurological sequelae are only some of the issues that the growing number of 
long-term surviving patients and their families face. Therefore, it is of utmost importance to 
consider health-related quality of life (HrQoL) as a major outcome parameter for this patient 
group besides medical and biochemical measures (Matza et al., 2004).  
HrQoL is defined as “a patient’s perception of the impact of disease and treatment on 
functioning in a variety of dimensions, including physical, psychological and social domains” 
(Varni et al. 1999, p.126). Due to the subjectivity of this construct, self-assessments by pa-
tients are the preferred data source (Matza et al., 2013). However, although self- and proxy 
assessments e.g. by parents often differ, parents can be very valuable as an additional source 
of information, especially in young or severely affected patients (Upton et al., 2008).  
There are three main types of HrQoL assessment tools. Generic tools such as the Ped-
sQL (Varni et al., 1999) target the general population and allow comparison between healthy 
individuals and individuals affected by any kind of disease. Chronic-generic tools such as the 
DISABKIDS (The DISABKIDS Group Europe, 2006) allow more specific comparison be-
tween individuals affected by different diseases. Disease-specific tools such as the PKU-
QOL (Regnault et al., 2015) investigate the impact of a particular disease or disease group 
on patients’ life. They have shown high responsiveness to change of HrQoL (S. Wiebe et al., 
2003) and  are therefore the method of choice for measuring this outcome parameter in clin-
ical trials or long-term patient management.  
No such disease-specific instrument was available for IT-IEM (Zeltner et al. 2014). We 
therefore developed a questionnaire of this type, the MetabQoL 1.0, following the ISPOR 
Guidelines (Matza et al., 2013). Four versions were constructed: self- and parent reporting 
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versions for patients from 8-18 years and self- and parent reporting versions for patients 
younger than 8 years. The development process encompassed three main steps. First, focus 
group interviews were performed to identify core topics with high content validity; details of 
the procedure and results have been reported elsewhere (Zeltner et al., 2016). Items were 
constructed based on focus group results and the available literature (e.g. The DISABKIDS 
Group Europe 2006; Regnault et al. 2015).  
This paper describes the second and third steps of the questionnaire’s development for 
the patients’ group aged from 8 to18 years. The second step was the exploration and adapta-
tion of item comprehensibility and clarity (“cognitive debriefing”) in children, adolescents, 
and adults. The third step was the psychometric evaluation of the instrument in a larger group. 
Item descriptives (e.g. mean, missing values, selectivity) served to select the most useful 
items, internal consistency of the questionnaire was calculated to assess reliability, and cor-
relations between scores of the new instrument and those of well-established generic HrQoL 
questionnaires were used to test for convergent validity. 
 
3.3. Methods  
 Subject recruitment  
For the cognitive debriefing, healthy children and adolescents as well as paediatric pa-
tients with UCD, OAs, or maple syrup urine disease (MSUD) from 8 to18 years were re-
cruited in Innsbruck and Zurich to test the comprehensibility and feasibility of the 
questionnaire booklet. Patients who had received a liver transplant for treatment of their met-
abolic disease were asked to recall the period before transplantation. 
For psychometric evaluation, a sample of families with at least one child diagnosed 
with UCD or OA aged 8-18 years from the metabolic centres of Düsseldorf, Hamburg, Hei-
delberg, Innsbruck, and Zurich was invited by a member of the local medical team to partic-
ipate in the study. Transplanted patients were not included.  
For both study phases (cognitive debriefing and psychometric evaluation), individuals 
were excluded if they had insufficient command of the German language or were incapable 
of answering the questions due to neurocognitive constraints.  
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Materials  
Questionnaire booklets were created for patients and parents. Patient self-report ques-
tionnaire booklets and parent proxy-report questionnaire booklets both contained basic de-
mographic items, the newly developed questions for the MetabQoL 1.0 instrument, and well-
established HrQoL questionnaires (described below). Parents worked on the booklet inde-
pendently, while patients answered all questions in a one-to-one interview with a trained 
interviewer with medical or psychological background at their homes or at the hospital. 
 
MetabQoL 1.0  
Patient and parent questionnaires included the set of newly developed items for the 
MetabQoL 1.0 instrument. The items were elaborated by discussion among four of the au-
thors (N.A.Z., M.L., M.B., M.H.); they were originally written in German and were translated 
into English for presentation in this report.  
A set of 52 questions was developed for parallel self- and proxy assessment for patients 
from 8 to 18 years. Fifty questions are answered using 5-point Likert frequency scales (op-
tions: never, seldom, sometimes, often, always), with an additional answer option (e.g. “no 
problem with this”) for questions not applicable for all patients (e.g. tube feeding). Two ques-
tions assess disease severity during the last 12 months: 1) disease has been “not bad at all”, 
“slightly bad”, “medium bad”, “bad”, “very bad” and 2) number of hospital admissions 
“never”, “once”, “twice”, “3 to 5 times”, “6 times or more”. Item scores can be aggregated 
to scale scores, which represent the core dimensions of physical, mental, and social HrQoL 
and a HrQoL total score.  
 
PedsQL and DISABKIDS 
Patients’ generic and chronic-generic HrQoL was assessed using self- and proxy as-
sessment versions of the PedsQL (Felder-Puig et al., 2004; Varni et al., 1999) and the 
DISABKIDS-37 (The DISABKIDS Group Europe, 2006); both instruments are reliable in 
terms of psychometric properties. 
The PedsQL is a well-established instrument to assess the generic HrQoL of children 
and adolescents from 8 to18 years with a recall period of four weeks. Twenty-three items are 
answered on a 5-point Likert frequency scale. The PedsQL has scale scores for physical, 
social, emotional, and school-related HrQoL. Social, emotional, and school-related HrQoL 
can be aggregated to a psychosocial health score. Sum scores of all scales represent the 
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HrQoL total score (Varni et al., 1999). The internal consistency of the PedsQL total scale 
scores in the current sample was good to excellent, with Cronbach’s α = 0.88 / 0.93 (self-
/proxy report). 
The DISABKIDS assesses HrQoL in children with chronic disease from 8 to 16 years 
with a recall period of 4 weeks. The answering format comprises 5-point Likert frequency 
scales. Six scales represent the three main dimensions of HrQoL: limitation and medication 
(physical HrQoL), independence and emotion (mental HrQoL), and inclusion and exclusion 
(social HrQoL). Furthermore, a total HrQoL score can be computed including all scales (The 
DISABKIDS Group Europe, 2006). The internal consistency of the DISABKIDS total scale 
scores in the current sample was good to excellent, with Cronbach’s α = 0.87 / 0.95 
(DISABKIDS self-/proxy report). 
 
Cognitive debriefing 
The MetabQoL 1.0 questionnaire was tested for comprehensibility, relevance, and fea-
sibility in a sample of five patients (n = 2 female, n = 3 male; age range = 8.72-16.77 years, 
mean = 12.42 ± 4.05 years; n = 1 liver transplanted) and their parents (n = 5 mothers). After 
completing the questionnaire one-to-one interviews were conducted at the patient’s home, at 
the hospital or by phone. Feasibility of the whole booklet for psychometric evaluation con-
taining all three HrQoL questionnaires (MetabQoL 1.0, PedsQL, DISABKIDS) was assessed 
by interviewing four healthy participants (n = 2 female, n = 2 male; age range = 9.83-18.09 
years, mean = 12.66 ± 4.36 years) at home. All comments were discussed, and two of the 
authors (N.A.Z., M.H.) decided adaptations to the booklet.  
 
Psychometric evaluation 
Cases were excluded if ≥ 20% of the MetabQoL 1.0 data were missing. The random-
ness of the remaining missing data was analysed with Little’s MCAR test to ensure that the 
imputation method was appropriate. Missing values in the MetabQoL 1.0 were then imputed 
using the full information maximum likelihood (FIML) method (Arbuckle, 1996). 
The PedsQL and the DISABKIDS were scored according to the corresponding manuals 
(The DISABKIDS Group Europe, 2006; Varni et al., 1999). Original scores of the MetabQoL 
1.0 (never / not applicable = 0, seldom = 1, sometimes = 2, often = 3, always = 4) were 
rescaled to values between 0 and 100 (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0). Values of 
positively formulated items were reversed to allow comparability with PedsQL and 
DISABKIDS. Accordingly, best HrQoL was indicated by values of 100, worst by 0. Scales 
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of physical, mental, and social HrQoL were computed by the mean of the corresponding item 
values. A total score was computed by the mean of all item values of the physical, mental, 
and social scales.  
Item selection was performed in two steps. The first step was based on cut-offs derived 
from the literature (Bühner, 2011) and the distribution of item descriptives in the current 
sample. Items were considered for exclusion if their mean value was ≥ 90 / 85 (self-/proxy 
report), or if selectivity was < 0.3, or if correlation with other items was ≥ 0.80, or missing 
raw data was > 5% (indicating e.g. low acceptance of an item), or if lack of comprehensibility 
had been documented in the interview setting. 
The second selection step consisted of screening these problematic items. Items re-
mained in the instrument if their content was vital to cover main issues from the focus groups, 
or in the interest of parallel content and comparability of the self- and proxy report question-
naires. 
Reliability defined as internal consistency for total and scale scores was determined 
using Cronbach’s alpha. Scores ≥0.7 were considered acceptable (Scientific Advisory 
Committee of the Medical Outcomes Trust, 2002). Concurrent validity between MetabQoL 
1.0 and PedsQL/DISABKIDS subscales and total scores was determined by Spearman cor-
relations. Due to the small sample size, factor analysis models were not applicable (Bühner, 
2011). 
Analyses were performed with the statistical software package SPSS, version 22.0 and 
Amos Version 23.0 for Windows (IBM Corp. IBM SPSS Statistics for Windows. Armonk, 
NY: IBM Corp). A predefined significance level of p < 0.05 was set for all tests.  
3.4. Results 
Sample characteristics 
Of 87 families approached, 46 (53%) participated in the psychometric evaluation. This 
resulted in a sample of 80 participants; 38 patients (n = 17 female, n = 21 male; age range = 
7.86 – 17.77 years, mean age = 12.56 ± 3.03 years; n = 25 OA, n = 13 UCD) with IT-IEM 
and 42 parents (n = 35 mothers, n = 7 fathers) of children with IT-IEM (n = 19 female, n = 
23 male; age range = 8.49 – 18.34 years, mean age = 13.42 ± 3.04 years; n = 27 OA, n = 15 
UCD; 32 parent-child pairs).   
 
Cognitive debriefing results 
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Overall, patients and parents reported good feasibility of the MetabQoL 1.0 and the 
validation booklet. The majority of the questions were considered comprehensive and rele-
vant by patients and parents. The guidance of the interviewer was important to improve pa-
tients’ concentration and ensure that they understood the questions. Some questions 
(addressing e.g. motoric function, tube feeding) were not applicable for all patients, but their 
parents were aware of their relevance for other patients. Five questions had to be rephrased 
to increase comprehensibility and one to increase relevance.  
 
Psychometric evaluation results 
The self- and proxy questionnaires showed 6.01% / 1.31% of randomly missing data 
in the MetabQoL 1.0 (Little’s MCAR-test, x2 = 10.02 / x2 = 464.94, DF = 292 / DF = 492, p 
= 1.00 / p = 0.80), and therefore qualified for the application of data imputation. 
 
Item selection 
The item selection process resulted in a final sample of 28 items. Selected items and 
their scale affiliation, representing the first version of the MetabQoL 1.0, are listed in Table 
1. Detailed item descriptives and the selection process of all items are shown in supplemen-
tary Table S1.  
 
Table 7: Items included in the first version of the MetabQoL 1.0 for self-assessment 
Items*1 included based on item analysis*2 Scale 
1 Does it bother you that you are not allowed to eat anything you want? Physical 
2 Does it bother you that you have to eat even when you are not hungry? Physical 
3 Does it bother you that you have to take medications? Physical 
4 Does the taste of your medications bother you? Physical 
5 Does it bother you that you have regular check-ups? Physical 
6 Are you afraid of having blood taken? Physical 
7 Does it bother you that you may have to go to the hospital due to an emergency? Physical 
8 Do you worry about your blood test results? Physical 
9 
Does your metabolic disorder bother you when you are playing or during other activi-
ties? 
Physical 
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10 Does it bother you that you cannot move as well as others? Physical 
11 Does it bother you that you get tired quickly? Physical 
12 Does it bother you that you often feel sick to your stomach? Physical 
13 Does it bother you that you have a feeding tube? Physical 
14 
Do you have trouble keeping up in school / in your apprenticeship because of your 
metabolic disorder? 
Mental 
15 Do you feel alright? Mental 
16 Are you worried about your metabolic disorder? Mental 
17 Are you sad because you have a metabolic disorder? Mental 
18 Are you angry at having a metabolic disorder? Mental 
19 Are you afraid of the future because of your metabolic disorder? Mental 
20 
Are you having problems doing things with friends because of your metabolic disor-
der? 
Social 
21 Are others less willing to be friends with you because of your metabolic disorder? Social 
22 
Does it bother you that your parents or others in your family are particularly worried 
about you because of the metabolic disorder?  
Social 
23 
Does it bother you that people treat you differently because of your metabolic disor-
der? 
Social 
24 Does it bother you that many people do not understand your metabolic disorder? Social 
25 Do you get left out because of your metabolic disorder? Social 
26 Does it bother you when other people feel sorry for you? Social 
27 How bad were your problems with your metabolic disorder over the last 12 months? Severity 
28 
In the past 12 months, how often did you have to be admitted to the hospital in an 
emergency? 
Severity 
*1 The proxy-assessment questionnaire consists of parallel rephrased items (e.g. item 1: Does it 
bother your child that he/she is not allowed to eat anything he/she wants?)  
*2 Answering options: never, seldom, sometimes, often, always (items 1-26); not bad at all, slightly 
bad, medium bad, bad, very bad (item 27); never, once, twice, 3 to 5 times, 6 times or more (item 
28) 
 
 
Reliability 
Psychometric properties of the MetabQoL 1.0 scales and their correlations are summa-
rized in Table 2 and 3. Means and skewness were higher for self-reported HrQoL than for 
proxy-reported HrQoL. Floor effects were not present, in contrast to ceiling effects, which 
were more dominant in self-reports than in proxy reports. Overall, reliability in terms of in-
ternal consistency was acceptable to excellent throughout all scales and total scores with a 
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range of Cronbach’s α = 0.70 – 0.93, which was generally higher in proxy reports than in 
self-reports. All scale intercorrelations of the MetabQoL 1.0 were significant, ranging r = 
0.60 – 0.96.  
 
Table 8: Psychometric properties of the MetabQoL 1.0 questionnaire 
 
Descriptive statistics 
        Reliability 
Scale 
N 
Items Mean SD Median 
Skew-
ness % Floor % Ceiling Cronbach's α 
    
Self 
Proxy 
Self  
Proxy 
Self 
Proxy 
Self  
Proxy 
Self 
Proxy 
Self 
Proxy 
Self 
Proxy 
Physical 
13 
81.68 
69.92 
14.70 
20.75 
84.16 
71.15 
-0.92  
-0.78 
0 / 0 
13.2 
2.4 
0.77 
0.90 
Mental 
6 
85.42 
71.63 
15.43 
20.58 
89.58 
77.08 
-1.36 
-0.27 
0 / 0 
23.7 
9.5 
0.70 
0.81 
Social 
7 
86.47 
72.87 
15.60 
20.22 
92.86 
73.21 
-1.19 
-0.36 
0 / 0 
26.3 
14.3 
0.70 
0.81 
Total 
score 26 
83.83 
71.11 
13.39 
18.68 
87.98 
71.15 
-0.95 
-0.32 0 / 0 
5.3  
2.4 
0.88 
0.93 
Disease-
severity 
2 
81.25 
75.30 
21.89 
26.69 
87.50 
87.50 
-1.34 
-1.12 
0 / 0 
39.5  
31.0 
 
 
Validity 
Convergent validity between the MetabQoL 1.0 and PedsQL / DISABKIDS was pre-
sent and generally higher for the DISABKIDS than for the PedsQL (Table 4). Correlations 
were not limited to corresponding scales but also present between non-corresponding scales 
(e.g. MetabQoL 1.0 physical scale with PedsQL scales).  
3.5. Discussion 
This study presents the development process of the first disease-specific HrQoL ques-
tionnaire for paediatric patients with IT-IEM, the MetabQoL 1.0.  The content validity of the 
questionnaire in general was ensured by involving patients and their parents in focus group 
interviews at the very beginning of the questionnaire development process (Zeltner et al., 
2016). Questions for self- and proxy-assessment were constructed based on statements from 
the focus groups. Cognitive debriefing was performed to further refine and focus the items 
of the questionnaire and to gain a first impression concerning the practical applicability of 
the instrument. Testing of the questionnaire in a larger sample of IT-IEM patients was con-
ducted to analyse its psychometric properties.  
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Table 9: Scale intercorrelations of the MetabQoL 1.0 
Scales   correlation coefficient 
    self / proxy 
Physical - Mental 0.67* / 0.75* 
Mental - Social  0.60* / 0.77* 
Social - Physical 0.66* / 0.77* 
Total score - Physical 0.96* / 0.95* 
Total score - Mental 0.78* / 0.86* 
Total score - Social 0.79* / 0.90* 
Severity – Physical 0.53* / 0.57* 
Severity – Mental 0.48 * / 0.41* 
Severity - Social 0.48* / 0.55* 
Severity – Total score 0.55* / 0.57* 
*p < 0.05 
 
Reliability in terms of internal consistency was acceptable to excellent for all scales 
and total scores. A general tendency towards high HrQoL was observed. This is consistent 
with data from other disease-specific questionnaires (Bullinger et al., 2015; Regnault et al., 
2015). Correlation with the PedsQL and DISABKIDS scales was investigated to examine 
concurrent validity. Correlations in a medium range indicated that, beyond measuring the 
construct of HrQoL in general, the MetabQoL 1.0 – as intended – adds specific content and 
information. This result underscores the benefit of this disease-specific questionnaire. As ex-
pected, correlations with the chronic-generic instrument, DISABKIDS, were higher than with 
the generic instrument, PedsQL. Since the DISABKIDS specifically addresses a population 
with health conditions, conceptualization of HrQoL was closer to the MetabQoL 1.0. Never-
theless, due to its more specific content we hypothesise that the MetabQoL 1.0 will be more 
responsive to disease-related changes than the chronic-generic DISABKIDS (S. Wiebe et al., 
2003) and thus most valuable for clinical practice and research settings. This hypothesis will 
be followed-up in long-term studies.  
Generally, the results of proxy assessment were more favourable in terms of psycho-
metric validity than the results of self-assessment. Self-assessment revealed higher means, 
increased skewness, lower reliability scores, and considerable ceiling effects for the mental 
and social scales. The modality of data collection may have influenced the answers; parents 
completed the questionnaires independently while children were interviewed. The focus 
groups performed at the beginning of the questionnaire’s development allowed space to 
freely express and discuss opinions and feelings, encouraged by exchange with other affected 
patients. The standardized questionnaire interview is a less open communication situation 
and may have favoured socially desirable answers. This idea is supported by the observation 
Empirical research   –    74 
 
that, in contrast to focus group interviews, where stigmatization was a central topic (Zeltner 
et al. 2016), patients neglected this issue in the individual interview situation.  
 
Table 10: Correlation coefficients between the MetabQoL 1.0 and the PedsQL (generic) / DISABKIDS (chronic-
generic) 
  PedsQL   DISABKIDS  
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cal 0.36* 0.43* 0.44* 0.41* 0.57* 0.52*  0.59* 0.57* 0.57* 0.55* 0.41* 0.47* 0.70* 
Mental 0.20 0.34* 0.23 0.43* 0.47* 0.36*  0.50* 0.57* 0.57* 0.69* 0.41* 0.53* 0.69* 
Social 0.33* *0.47 0.28 0.26 0.42* 0.40*  0.53* 0.47* 0.53* 0.56* 0.27 0.43* 0.57* 
Total 0.37* 0.46* 0.45* 0.41* 0.57* 0.52*  0.63* 0.64* 0.63* 0.61* 0.43* 0.52* 0.75* 
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cal 0.62* 0.51* 0.63* 0.52* 0.69* 0.72*  0.84* 0.62* 0.65* 0.67* 0.57* 0.74* 0.79* 
Mental 0.45* 0.60* 0.59* 0.47* 0.67* 0.62*  0.68* 0.79* 0.58* 0.86* 0.52* 0.86* 0.84* 
Social 0.67* 0.61* 0.72* 0.46* 0.73* 0.75*  0.82* 0.57* 0.73* 0.71* 0.70* 0.76* 0.85* 
Total 0.63* 0.59* 0.71* 0.53* 0.75* 0.75*  0.86* 0.72* 0.71* 0.78* 0.65* 0.83* 0.89* 
*p < 0.05 
*1 Sample size for convergent validity analysis was n = 37 in self-report (n=1 excluded due to complete missing 
of DISABKDIS and PedsQL scores) and thereby different from all other psychometric analyses  
 
Higher self-ratings than proxy-ratings of children’s HrQoL in health care are well 
known from the literature (Eiser & Jenney, 2007; Jamiolkowski et al., 2016). Children have 
a more intuitive, spontaneous view of a situation than adults and a tendency towards extreme 
answers (Chambers, 2002). Furthermore, the effects of fatigue may be more prominent in 
children and adolescents than in adults and may have led to a lack of concentration during 
the interviews. This assumption is supported by the results of the cognitive debriefing, which 
emphasized the necessity of an interviewer guiding the patients through the questionnaire 
booklet to maintain concentration. Some IT-IEM patients have neurocognitive deficits, and 
their chronological age may not fully reflect their developmental age and concentration abil-
ities. To reduce this bias, the questionnaire was kept as short as possible, with 28 items after 
psychometric evaluation. Furthermore, the more comprehensible 10-item smiley version of 
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the MetabQoL 1.0 instrument for patients younger than 8 years, which is currently under 
development, may also prove useful in older patients with cognitive impairment.  
Notably, 83% of the participating parents were female. In research about paediatric 
patients, higher representation of mothers compared to fathers is a well-known phenomenon 
(Goldstein et al., 2013) and may limit the generalisability of parent-reports.  
 
The pattern of correlation between the MetabQoL 1.0 scales and the PedsQL and 
DISABKIDS scales showed not only correlations between corresponding scales of the three 
instruments but also correlations between non-corresponding scales. Furthermore, correla-
tions were observed between total score, physical, mental, and social scales of the MetabQoL 
1.0. Highest correlations were found between physical HrQoL and the total score, which is, 
however, partly due to the large number of items these scores share. Overall, these findings 
lead to the hypothesis that there may be only a single dimension behind the items of the 
MetabQoL 1.0. The concept of the classical three dimensions of HrQoL is under discussion, 
and others have proposed the sole use of a single total HrQoL score (Solans et al., 2008). 
Particularly in IT-IEM, the influence of the disease on patients’ lives may be global. Physical 
aspects such as diet have a strong influence on social and mental aspects (feeling different or 
socially excluded). IT-IEM predominantly affect the brain. Therefore, cognitive functioning 
is strongly associated with the physical dimension. This association seems specific and is not 
present in the majority of generic HrQoL questionnaires for children (Rajmil et al., 2004) in 
which cognitive and emotional functioning constitute an independent mental dimension.  
Factor analysis, which might have elucidated the structure of the MetabQoL 1.0 in more 
detail, could not be performed due to the sample size (MacCallum, Widaman, Zhang, & 
Hong, 1999). Although the international character of this study increased sample size, the 
diseases are rare, and large patient samples can only be gathered over time. Therefore, the 
questionnaire will be translated to be applied in larger samples in the near future. Further 
psychometric exploration will also include analyses of criterion validity, which was not ad-
dressed in this study. Criterion validity refers to the ability of a questionnaire to distinguish 
between different groups of patients. Furthermore, a larger sample may allow providing nor-
mative data. Normative data form the basis to compare between patients and to describe an 
individual’s position within the reference group, which clearly is of long-term scientific in-
terest. For now, the MetabQoL 1.0 is a tool to identify profiles of concerns and strains an 
individual patient experiences and opens the field for targeted clinical counselling. Further-
more, changes of a patient’s HrQoL over time or under different treatment conditions can be 
monitored. These uses are not bound to normative data. 
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The MetabQoL 1.0 may be applied in clinical practice as well as in research, especially 
to detect changes in HrQoL over time. In clinical practice, monitoring HrQoL over time fa-
cilitates the identification of patients’ needs and emotional and social aspects of the disease, 
which may not easily be detected in clinical routine. Notably, impaired social HrQoL has 
been shown for IT-IEM before (Fabre et al., 2013). Interestingly, the use of HrQoL instru-
ments generally improves communication between patients and the medical team, which re-
sults in enhanced patients’ well-being (Velikova et al., 2004). This is of particular importance 
during transitional phases such as transition to kindergarten, to school, and to adolescence 
(Khangura et al., 2015; Packman et al., 2012), when the impact of the disease and specific 
needs may change.  
Considering research, disease-specific HrQoL measures are a most interesting addi-
tional approach for measuring outcome in clinical trials (S. Wiebe et al., 2003). The 
MetabQoL 1.0 is a promising tool for assessing disease-related HrQoL changes in IT-IEM. 
Furthermore, the questionnaire facilitates the exploration of predictors of HrQoL in IT-IEM 
patients and the development of interventions targeting patients’ needs. 
 
Conclusion 
 The MetabQoL 1.0 is the first psychometrically evaluated HrQoL questionnaire ad-
dressing the specific impact of IT-IEM on patients. Its targeted approach - in contrast to ge-
neric measures- renders the MetabQoL 1.0 a valuable measure in clinical and research 
settings. Translation into other languages and further evaluation will allow broader applica-
tion of the instrument.  
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1. Summary of the results 
The objective of this dissertation was to develop and psychometrically evaluate the first 
disease-specific HrQoL assessment tool for patients with IT-IEM. This was achieved 
utilizing a multidimensional approach, which is presented in three publications and finally 
the questionnaire MetabQoL 1.0. Questionnaires were constructed for two patient groups: 
those ranging in age from 8 to 18 years and patients younger than 8 years. Each questionnaire 
was created with parallel versions for patient- and proxy-responders.  
A systematic literature review (first publication) laid down the foundation for this 
research, particularly by highlighting the need for a disease-specific instrument to assess 
HrQoL in this patient population (Zeltner et al., 2014). The second publication (Zeltner et al., 
2016) presented the results of a systematic content analysis of focus group work with patients 
and parents. Statements were allocated to categories representing the issues that patients 
reported. The third and final manuscript presented in this thesis (Zeltner et al., in press) 
describes the development and evaluation process used for the first disease-specific 
questionnaire for paediatric IT-IEM patients from 8 to 18 years. A version of the MetabQoL 
1.0 for younger patients was also developed over the course of this thesis project, and its 
evaluation is planned for the future. All MetabQoL 1.0 questionnaire versions developed in 
the project are presented in the additional materials section of this thesis.  The methods and 
results of the three manuscripts are summarized in Table 11.  
This general discussion section will first reflect on the questionnaire development 
process, including its strengths and limitations. Secondly, it will provide a closer look at the 
resulting HrQoL questionnaire, by analysing its quality. Thirdly, implications will be drawn 
for future research and clinical practice. The section will end with a general conclusion.  
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Table 11: Overview of sample, methods, and main results of the three manuscripts 
Title  Health-related quality of life, psychological adjustment, and adaptive function-
ing of patients with intoxication-type inborn errors of metabolism - a systematic 
review   
Methods Main inclusion criteria for articles: Quantitative outcome regarding HrQoL, psycho-
logical adjustment, or adaptive functioning; IT-IEM patients; n > 1 
 
Analysis: Systematic review   
Main results - 11 articles satisfying inclusion criteria 
- HrQoL: inconsistent results 
- Psychological adjustment and adaptive behaviour: IT-IEM patients exhibited no 
difference to or worse adjustment than reference populations 
- Risk factors: few medical and no psychosocial risk factors were assessed 
- Methodological limitations: Various approaches and assessment measures were 
used across the studies – pooling of results is not possible; no disease-specific 
assessment tool was identified 
    
Title  Living with intoxication-type inborn errors of metabolism - a qualitative analysis 
of interviews with paediatric patients and their parents   
Sample N total = 45; n = 19 patients with IT-IEM; n = 26 parents 
 
Recruited age range of patients: 7-18 years (patient-report); 0 – 18 years (parent-re-
port) 
  
Involved centres: Dusseldorf, Hamburg, Innsbruck, Zurich 
  
Methods Assessment: Focus groups and single interviews 
 
Analysis: Systematic content analysis   
Main results - 14 categories allocated to physical, mental, and social dimensions of HrQoL were 
identified 
- Comments regarding dietary restrictions and stigmatisation / exclusion were most 
often made by both patients and parents 
- The relative importance of categories (measured by number of statements per 
category) varied depending on the age of the patient or informant (patient / parent) 
    
Title  Development and psychometric evaluation of the MetabQoL 1.0 - a quality of life 
questionnaire for paediatric patients with inborn errors of metabolism   
Sample N total = 80; n = 38 patients with IT-IEM, n = 42 parents 
 
Recruited age range patients: 8-18 years 
 
Involved centres: Dusseldorf, Hamburg, Heidelberg, Innsbruck, Zurich 
  
Methods Materials: Questionnaire booklet including MetabQoL 1.0, DISABKIDS, PedsQL 
 
Assessment: Face-to-face interviews (patients) or paper-pencil (parents) 
 
Analysis: Psychometric evaluation: item selection based on item descriptives, reliabil-
ity, validity   
Main results - Item selection based on item characteristics: 28 items remaining  
- Reliability: Acceptable to excellent (Cronbach’s α = 0.70 to 0.93) for all scales 
- Validity: Concurrent validity (significant correlation of scales) with DISABKIDS and 
PedsQL 
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2. Reflection of the questionnaire development process with its 
strengths and limitations 
The MetabQoL 1.0 was developed carefully in accordance with current guidelines on 
patient-reported outcomes in paediatrics (Matza et al., 2013). As a first step, a systematic 
literature search served to clarify the current state of research in the field, including which 
assessment instruments have been used. Although research was found to be sparse, its in-
crease over the last 10 years indicates growing interest in studying psychosocial outcomes in 
IT-IEM patients. The lack of a disease-specific assessment tool was apparent. The subse-
quently-developed MetabQoL 1.0 fills this gap.  
To enhance the questionnaire’s validity, we then sought patient and parental perspec-
tives. Focus groups were conducted with families from four involved metabolic centres, and 
psychometric evaluations with families from five centres. Several authors have pointed out 
the importance of patient, and not only parent, involvement in HrQoL assessments (Matza et 
al., 2013; Solans et al., 2008). Proxy-assessments are used more commonly in paediatric than 
adult HrQoL research (Solans et al., 2008) and more commonly than patient- assessments 
when studying IT-IEM (Zeltner et al., 2014). The main reason for this may be the high degree 
of effort required for patient involvement. Despite this habitual practice, we strove to include 
as many IT-IEM patients as possible in all steps of questionnaire development and evalua-
tion. The setting of focus groups was well suited for patient involvement, since the questions 
asked were readily adaptable to ensure their comprehensibility and, thereby, spur lively dis-
cussions. The presence of other patients in the focus groups also helped the children and 
adolescents to more freely discuss their concerns about their metabolic disease.  
We also sought to provide an appropriate setting during the psychometric evaluation 
phase. Face-to-face interviews were conducted, with clear explanations and examples pro-
vided at the beginning of each evaluation session. Also, all interviewers were instructed to 
pause whenever necessary or otherwise appropriate. These measures enhanced patient in-
volvement so that we acquired more than just parental input. This being said, the parents’ 
perspectives yielded important additional information to our dataset during focus groups and 
psychometric evaluations. This was especially important for those patients who were unable 
to participate due to young age or severe neurocognitive impairment, a group of patients for 
whom data only were available via their parents. 
Despite our best intentions, our aim to involve as many patients as possible during 
questionnaire development created several challenges relating to the age and developmental 
level of IT-IEM patients. The tool used for each psychometric evaluation was selected purely 
based on the given patient’s chronological age. As such, all patients eight-years-old and older 
were assessed using the MetabQoL 1.0 version for older children and adolescents, even 
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though several IT-IEM patients had neurocognitive deficits, and certain 8-year-olds may 
have had difficulties coping with the more complex or abstract questions included in this 
questionnaire. A simpler measure with smiley-face rating scales, as developed for patients 
younger than eight, would likely have generated more accurate and meaningful responses in 
such cases. Using patient’s developmental rather than chronological age to decide which 
questionnaire to choose would seem reasonable, particularly among patients at or near the 8-
year threshold. However, determining the developmental age of each child at every partici-
pating clinic would have posed a major challenge.  
Furthermore, the choice of patient interview modality used might have introduced its 
own errors and biases. HrQoL ratings by patients were higher than expected, especially for 
the social scale. Higher HrQoL scores during self-assessments have been well described in 
the literature (Bullinger et al., 2013; Regnault et al., 2015), and this might also occur, poten-
tially even exacerbated, during face-to-face interviews. Thus, the setting itself might have 
created some degree of social desirability bias. Patients reported few social problems during 
the MetabQoL 1.0 interviews, contrary to the focus group discussions. Standardised face-to-
face interviews might have been viewed as a less open communication scenario than focus 
group discussions, wherein patients exchanging experiences might have helped some to 
speak more openly about their problems. Reporting few social problems might be rooted in 
a child’s or adolescent’s desire to represent him- or herself as popular and liked by friends. 
Similarly, youths might have a tendency to want to present themselves as brave to their in-
terviewer (e.g., not afraid of blood tests; not bothered by having to take medication). A more 
accurate account of their feelings might be obtained in the more anonymous setting of a writ-
ten questionnaire, as it was done during proxy-assessments with parents. On the other hand, 
in-person interviews were deemed more feasible for children, since the interviewer could 
answer any questions the patients had about the questionnaire content, thereby facilitating 
their responses. In the end, we chose to enhance survey feasibility at the risk of increasing 
social desirability bias.   
Any study on a rare disease faces challenges due to both the small research community 
and the limited patient population. Efforts were therefore made from the beginning to attain 
support from a wide range of researchers beyond national borders. Metabolic centres in Aus-
tria and Germany were found for collaboration. Participating research physicians were cru-
cial to patient recruitment, and furthermore provided fruitful input that served to enhance the 
study methodologically. To strengthen the theoretical background of test development, we 
engaged in lively exchanges with researchers spearheading the DISABKDIS and QoLISSY 
projects (Bullinger et al., 2013; The DISABKIDS Group Europe, 2006), who provided ample 
valuable experience developing questionnaires. 
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Despite these collaborative efforts, the major limitations associated with questionnaire 
development still pertain to the small sample of patients. The underlying reason for this, of 
course, is the rarity of the diseases of interest, which could not be fully offset, even with 
multiple centres recruiting subjects. Since the MetabQoL 1.0 was solely developed in Ger-
man, the patient population available to contribute to its development and evaluation also 
was limited to German speakers. Parallel development of the questionnaire in several lan-
guages, as done elsewhere (Regnault et al., 2015; The DISABKIDS Group Europe, 2006; 
The KIDSCREEN Group Europe, 2006) would have helped to overcome this problem. How-
ever, the scope of the project would have needed to be expanded considerably. The first pub-
lication in this thesis (Zeltner et al., 2014) has already described the problematic impact of 
small sample sizes in previously-published studies. The focus groups could also have bene-
fited from additional participants, though smaller subject samples are considered less of an 
issue with qualitative than quantitative analysis, as conducted here. The representativeness 
of the sample was deemed more critical. In our study, the sample’s representativeness — in 
terms of patient characteristics like age, gender, and general medical condition (e.g., tube 
feeding, physical limitations like difficulty walking) — was ensured by the recruiting physi-
cians.  
Ultimately, the limited sample size was most problematic during the psychometric 
evaluation of the instrument. All data collected were stratified into the two versions of the 
MetabQoL 1.0 created (for patients < 8 versus 8 to 18 years). This aggravated the problem 
of sample size. In the end, we were forced to forego evaluating the questionnaire version for 
younger children psychometrically, limiting our analysis (as described in the third manu-
script) to the self- and proxy-versions of the MetabQoL 1.0 for older children and adoles-
cents. Even so, small numbers still hampered some statistical procedures. One casualty of the 
low numbers was our intended confirmatory and exploratory factor analysis to shed light on 
the dimensionality of our questionnaire, since it failed to reveal meaningful results. In all 
likelihood, this relates to the sensitivity of factor analysis to sample size (MacCallum et al., 
1999). Several guidelines recommend that larger samples are best for factor analysis, though 
some have argued that factor analysis can be performed on samples with as few as 60 sub-
jects, if the circumstances are favourable (e.g., with communality ratings of 0.60 – 0.80 be-
tween items) (Bühner, 2011). Unfortunately, despite our efforts, our sample size even fell 
below these tolerance guidelines, and all our attempts at factor analysis were unsuccessful.  
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3. Reflection of the quality of the MetabQoL 1.0 
The MetabQoL 1.0 questionnaire was the primary intended outcome of this thesis. 
Hence, its psychometric evaluation and how well it performed in terms of quality criteria will 
be discussed based on the criteria presented in the introduction. The main quality criteria 
(objectivity, reliability and validity) and other auxiliary quality criteria are listed again in 
Figure 9. Also indicated is whether the MetabQoL 1.0 for patients from 8 to 18 years either 
successfully satisfied or failed to adequately satisfy each individual criterion. 
 
 
Figure 9: Quality criteria tested on the MetabQoL 1.0 for patients from 8 to 18 years 
Green check marks indicate that the instrument successfully satisfied a criterion, while red crosses indicate 
failure to adequately satisfy a criterion 
 
The MetabQoL 1.0 satisfied the main quality criterion called objectivity. Standardisa-
tion of the questionnaire and detailed instructions for interviewers ensured objectivity to as 
great a degree as possible. This was of utmost importance, since the interviews were mostly 
completed at participant homes, so that the interview surroundings were not identical from 
one subject to the next. Evaluation and interpretation of the questionnaire was performed in 
a standardised way by the author of this thesis. It is crucial to note that a detailed manual is 
being drafted for use by other research groups or clinicians who choose to use the MetabQoL 
1.0 to ensure that objectivity is maintained. 
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Reliability was investigated by assessing the questionnaire’s internal consistency, and 
all scales satisfied this criterion. Moreover, since internal consistency can be considered an 
extension of split-half reliability, this criterion also was deemed satisfied. Test-retest relia-
bility was not evaluated, since HrQoL is a dynamic construct that is subject to change over 
time, which renders the relevance of test-retest reliability debatable. As such, finding low 
test-retest reliability could just as likely be caused by a real change in a patient’s HrQoL as 
by one or more inaccurate measurements. Moreover, assessing test-retest reliability would 
have required a second evaluation, causing undue stress and creating unnecessary burdens 
on participating patients and parents. The same applies to parallel-test reliability. For all these 
reasons, the questionnaire’s internal consistency was the only reliability criterion actively 
measured, and this was found to be adequate.  
In contrast, several validity constructs were evaluated. Content validity was verified by 
experts in the field, as suggested by others (Moosbrugger & Kelava, 2012). The multidisci-
plinary team that developed the questionnaire was an expert panel, all of whom contributed 
to ensuring that the questionnaire’s content was relevant to the issues of concern. Even more 
importance might be attributed to the opinions of patients and parents who participated in the 
focus groups. Their subjective experiences with the disease included a broad range of ways 
in which the disease impacted them, allowing us to create a tool that was deeply rooted in 
HrQoL as previously defined (Varni et al., 1999). In this way, the instrument’s content va-
lidity was verified by all major stakeholders.  
The criterion face validity, which refers to the extent that a questionnaire appears valid 
to laypersons at first appearance (Moosbrugger & Kelava, 2012), can be considered satisfied, 
since the questions were believed relevant during pilot testing, and acceptance was good 
overall in both the pilot test and psychometric evaluation.  
Making a judgement about construct validity is more complex. Significant correlations 
between the MetabQoL 1.0 and generic HrQoL scale scores suggest good concurrent validity. 
However, exploration of the questionnaire’s dimensionality, usually possible with factor 
analysis procedures, could not be performed because of the small sample size. This issue will 
be discussed further in the following sections considering directions for future research.  
Criterion validity also was not assessed in the evaluation of the MetabQoL 1.0. A test 
is said to have criterion validity if the test score can predict a “criterion” beyond the test 
situation (Moosbrugger & Kelava, 2012). In the case of disease-specific HrQoL, the physical 
HrQoL subscale could possibly be associated with the severity of the disease. Other studies 
have identified such things as group differences as a means to address criterion validity. For 
example, the quality of life in short-stature youth questionnaire (QoLISSY) (Bullinger et al., 
2013) is a condition-specific instrument whose score significantly distinguishes between 
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groups of different height. However, such different severity groups are difficult to form 
among IT-IEM patients. Required tube feeding might be viewed as one possible criterion 
with which to distinguish different levels of disease severity in IT-IEM patients. However, 
tube feeding may sometimes be necessary in patients having major problems with food in-
take, but who are otherwise relatively intact; while others with severe neurological or other 
manifestations of disease might still be able to accept food orally. Another criterion that 
might be used to delineate disease severity can be seen in the last two items of the MetabQoL 
1.0 questionnaire, in which severity of the disease over in the last year is asked about. How-
ever, these two items are non-objective measures, rated by the same person rating HrQoL, a 
rating that in our sample was strongly skewed towards a lower level of severity during ques-
tionnaire evaluation. A threshold to distinguish “more severe” and “less severe” cases could 
have been picked, but this in itself would need to be tested for criterion validity.  
The auxiliary criterion pertaining to scaling can be considered at least partially satis-
fied, in that precise instructions exist explaining how to aggregate individual item ratings in 
the MetabQoL 1.0 into summation scores. However, as the dimensionality of the MetabQoL 
1.0 requires further exploration, the scales could still be subject to change. Further psycho-
metric exploration could also contribute to standardisation, which cannot be provided at this 
level of questionnaire development and will need a larger sample. This being said, the pri-
mary aim of disease-specific HrQoL questionnaires is not for use rendering comparisons 
against reference populations; the MetabQoL 1.0 questionnaire is designed for use particu-
larly as an outcome measure in studies or in clinical settings to monitor HrQoL over time. 
Hence, its sensitivity to change and its specificity for disease-related issues are more critical 
characteristics. The sensitivity of the MetabQoL 1.0 to change has not yet been explored, but 
there is clear evidence that disease-specific instruments are more responsive to change than 
generic instruments (S. Wiebe et al., 2003).  
Furthermore, the MetabQoL 1.0 is economical and feasible to use, which was ensured 
by shortening the questionnaire and paying considerable attention to using language and a 
format suitable for a paediatric population. Despite these efforts, administering the question-
naire was challenging with some children and adolescents, which could be attributed to their 
young age or to neuro-developmental deficits. The question of how children up to age 12 
years understand health constructs remains to be clarified not only among IT-IEM patients, 
but in healthy children as well (Matza et al., 2013).  
The last criterion to be discussed here relates to the extent to which a test result can be 
falsified. Potential social desirability bias, possibly exacerbated by the in-person interview 
data collection format, was observed in the analysis (Zeltner et al., in press). The risk that 
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patients might falsify their responses to provide a more socially-desirable depiction of them-
selves (e.g., by reporting a higher quality of life or having numerous friends) is well-known 
in child-reported outcomes research (Bevans et al., 2010). 
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4. Considerations for future research and clinical practice  
4.1. Implications for future research 
The MetabQoL 1.0 serves as a solid basis to be evaluated in other, larger populations. 
The next step to be taken includes careful translation of the questionnaire into different lan-
guages, as per appropriate guidelines (Epstein, Santo, & Guillemin, 2015). Translation of the 
MetabQoL 1.0 into English is in progress, and plans are already in place for both versions of 
the questionnaire (<8 years and 8-18 years) to be tested psychometrically in the United States. 
This will provide sufficient data to finally evaluate the MetabQoL 1.0 for patients younger 
than 8 years. Furthermore, catching up on the evaluation performed in German for the version 
for patients from 8 to 18 years will allow for exploration of construct validity by factor anal-
ysis. Merging data sets of different languages can be taken into account if item characteristics 
are comparable among different-language samples. This would generate larger samples and 
thus, a greater quantity of data for more detailed analysis.  
Importantly, further evaluations of the MetabQoL 1.0 will allow for the current dimen-
sionality of the HrQoL construct to be critically reviewed. At the present time, summation 
scores can be calculated for three scales — physical, mental and social — as well as a total 
score from individual item scores for the MetabQoL 1.0 for patients from 8 to 18 years. The 
present results of psychometric evaluation suggest that there may be only one dimension 
underlying the items. As elaborated in the third manuscript in this thesis (Zeltner et al., in 
press), this may be rooted in the very global impact IT-IEM has on patients. However, our 
results do not allow for us to draw any definitive conclusions. Notably, different reviews 
revealed a broad range of diversity in HrQoL conceptualisations and the need for research to 
establish a more robust theoretical background for HrQoL in general (E. Davis et al., 2006; 
Solans et al., 2008).  
In the focus group study, parents frequently reported their own distress (Zeltner et al., 
2016). Other questionnaires that seek to assess a child’s HrQoL have included parent-centred 
questions in proxy-report versions (Bullinger et al., 2013; Regnault et al., 2015). Even though 
these questions are not direct indicators of the child’s HrQoL, they may provide interesting 
insights into internal family relationships. Furthermore, by demonstrating concern regarding 
not just the child’s but the parents’ feelings, they can enhance the questionnaire’s acceptabil-
ity.  
The MetabQoL 1.0 also facilitates future research on HrQoL in IT-IEM patients. The 
specific burdens of patients need to be explored. With its disease-specific content, the 
MetabQoL 1.0 provides ideal outcomes of interest for use in clinical trials and may be espe-
cially sensitive to disease-related changes (S. Wiebe et al., 2003), contrary to generic HrQoL 
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measures like the widely-used PedsQL (Varni et al., 1999). Relative to other fields of re-
search, in which the implementation of HrQoL instruments is usual practice, the MetabQoL 
1.0 will be a step towards implementation in IT-IEM research, as well. This will help us all 
to achieve the ultimate goal of developing medical interventions to best serve the patient, by 
including outcomes of importance to patients in addition to medical parameters (Bullinger, 
Schmidt, Petersen, Erhart, & Ravens-Sieberer, 2007). 
Future research should also examine factors that influence HrQoL, as this may help to 
identify successful interventions. The review at the beginning of this project revealed that a 
number of medical, but no psychosocial predictors had yet been explored (Zeltner et al., 
2014). However, psychosocial predictors may deserve special attention, as individual char-
acteristics like level of coping skills, as well as certain family characteristics have been shown 
to be important predictors of HrQoL in other settings (Landolt, Grubenmann, et al., 2002; 
Walterfang et al., 2013). Parental well-being after a child is diagnosed with a chronic disease 
has been shown to be a predictor of good recovery in the child (Landolt, Ystrom, Sennhauser, 
Gnehm, & Vollrath, 2012).  
Another interesting target for future research relates to patient adherence to diet and 
medication, which is desperately needed in IT-IEM patients. This responsibility has been 
found to be taken over by parents with very young children (Zeltner et al., 2016). Later on in 
childhood and during adolescence, patients usually take more and more responsibility for 
their health. However, it has been shown that diabetic children from 10-15 years of age ex-
hibit peak adherence and quality of life if they perceive their mothers to be collaborative 
regarding their diabetes, rather than either uninvolved or controlling (D. J. Wiebe, 2005). 
These findings underline the importance of a family system approach when investigating 
HrQoL, whether that is in research or clinical practice. In the long term, monitoring HrQoL 
and identifying which factors contribute most to it may serve to optimize interventions and 
thereby render accessible the best possible care for patients and their families. 
 
4.2. Implications for clinical practice 
Clinical implications first of all include application of the MetabQoL 1.0 in clinical 
settings, which may provide multiple benefits. First of all, HrQoL instruments are known to 
facilitate communication between patients and hospital staff (Velikova et al., 2004). They 
may furthermore help to identify problems which are not always addressed in routine con-
sultations (emotional and social issues), and help to monitor changes in patients’ state of 
health and response to treatment (Higginson & Carr, 2001). One must keep in mind that 
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HrQoL measures were never designed to replace other biomedical measures or medical ex-
aminations; rather, they are an ideal supplement to “ensure that treatment and evaluation 
focus on the patient rather than the disease” (Higginson and Carr 2001, p. 1297). For a HrQoL 
questionnaire to be put into practice, it is of great importance that its content covers the issues 
of interest for patients, and that its application and interpretation are as user-friendly as pos-
sible (Higginson & Carr, 2001). Content validity was ensured during development of the 
MetabQoL 1.0. However, an electronic version (e.g., on a tablet) that automatically interprets 
the questionnaire and can be given to patients and parents in the waiting room would be ideal. 
This concept can be pursued in future tool development.  
Some of the focus group findings have clinical implications as well. Besides generating 
categories of importance with which to construct our HrQoL questionnaire, the focus groups 
provided initial insights into the real-world problems that patients and families experience. 
This, in turn, not only illustrates the importance of providing better family support, but also 
which areas to focus on. One area of concern to many was how difficult it is to explain what-
ever complicated disease they are facing to others. This was found to pose a problem not only 
for very young children, but throughout all age groups, including parents. The metabolic 
department in Zurich has therefore started a project to develop and validate attractive pictorial 
materials, appropriate for children, to explain the genetics, biochemical basis and treatment 
options for metabolic diseases.  
Another finding that might have clinical practice implications was that social issues 
were raised as a major concern in focus groups, but not during face-to-face interviews. This 
emphasizes the importance of offering patients the right context in which to express their 
feelings and concerns. In the setting of focus groups, patients were able to exchange experi-
ences with other affected children and adolescents. Some of them stated that they really ap-
preciated this, and that they had never had any opportunity like this before. Hence, connecting 
patients with support groups could be very helpful. Unfortunately, however, the number of 
support groups is very limited amongst rare diseases, and accessing them typically is difficult 
due to the lack of information and prohibitive geographical distances (Anderson, Elliott, & 
Zurynski, 2013).  
In general, psychosocial care seems to be lacking for families with a child with a severe 
rare disease (Anderson et al., 2013), even though it is well-known that life-threatening con-
ditions adversely impact psychological health and functioning among paediatric patients and 
their families (e.g. Landolt et al., 2012; Long & Marsland, 2011). Standards exist for psycho-
social care for more common diseases like cancer (Wiener, Kazak, Noll, Patenaude, & Kupst, 
2015). Such standards and guidelines include steps like integrating psychosocial profession-
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als as integral team members in the hospital setting, performing routine assessments of pa-
tient’s psychosocial health care needs, and providing access to psychosocial support for pa-
tients, parents, and siblings (Wiener et al., 2015). These same interventions offered for cancer 
patients and their families could very well be helpful for IT-IEM patients as well. As for other 
diseases, not only patients but their parents and other family members warrant attention, due 
to the known inter-dependence between a child’s well-being and a variety of family charac-
teristics (Landolt et al., 2012). This need was highlighted in our focus groups, via the large 
number of comments parents made about their own distress (Zeltner et al., 2016).  
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5. General conclusion 
To our knowledge, the MetabQoL 1.0 is the first HrQoL questionnaire specifically de-
signed for use with IT-IEM patients. It was carefully developed by reviewing existing litera-
ture and orchestrating focus group discussions with IT-IEM patients and their parents to 
define contents. The focus group discussions were enlightening in other ways as well, provid-
ing glimpses into ways to improve support for patients and families.  
Evaluation of the questionnaire that was created was performed using a combined pa-
tient and parent sample, and revealed several robust psychometric properties of the 
MetabQoL 1.0, justifying its use both in research and clinical practice. Translation into other 
languages, testing it in other, larger IT-IEM samples, and further psychometric evaluation 
will help to delineate the instrument’s dimensionality, potentially leading to future refine-
ments. It is our hope that the MetabQoL 1.0 will serve as both as a means to enhance our 
understanding of how and in which ways these conditions most impact HrQoL; and, by doing 
so, to ultimately augment all aspects of care for IT-IEM patients and their families.  
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Appendix 
The following pages contain the questionnaires used for psychometric evaluation. Ver-
sions for patients aged from 8 to 18 years are displayed in their original length, as they were 
before item selection. 
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Questionnaire for patients from 8 to 18 years, patient-report 
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Questionnaire for patients from 8 to 18 years, parent-report 
 
Appendix   –    108 
 
 
109   –    Appendix    
 
 
Appendix   –    110 
 
Questionnaire for patients from 4 to 7 years, patient-report 
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Questionnaire for patients from 2 to 7 years, parent-report 
 
113   –    Appendix    
 
 
Acknowledgements   –    114 
 
Acknowledgements 
I am thankful to many people who supported me throughout this dissertation project. 
First of all, I want to thank all the children, adolescents and parents who participated in our 
studies and openly talked about how the metabolic disease affected their daily life. These 
encounters were the basis of our research and inspiring far beyond the information aggregated 
in the publications.  
I am very grateful to my supervisors at the Children’s Hospital, Markus Landolt, Mat-
thias Baumgartner, and Martina Huemer. Their scientific and motivational support funda-
mentally contributed to the success of this thesis and was an exceptionally enriching 
experience. A special thanks goes to Matthias Baumgartner who gave me the opportunity to 
be part of his lab among many other inspirational researchers and to attend several congresses 
with them. I am also very thankful to Guy Bodenmann, who was willing to supervise my 
thesis as a member of my doctoral committee.  
The fruitful collaborations with researchers of different hospitals were an important 
basis of this thesis project. In this regard, I want to thank all the physicians and psychologists 
who supported me with data collection and enlightening discussions: Regina Ensenauer, An-
drea Schlune, and Eva Thimm from Dusseldorf; Monika Bullinger, Chris Mühlhausen, Ra-
chel Sommer, and Julia Quitmann from Hamburg; Aljona Bondarenko, Peter Burgard, and 
Stefan Kölker from Heidelberg; Daniela Karall and Sabine Scholl-Bürgi from Innsbruck. 
Furthermore, I want to thank all my research colleagues from the radiz and Metabolics 
Team for their great interest in my field of work and their support and discussions during 
presentations. Besides, I thank all my fellow (Post-) Doctoral students at the Department of 
Psychosomatics and Psychiatry for the vivid exchange of ideas: Eva Alisic, Anke de Haan, 
Ann-Christin Haag, Didier Kramer, Ornella Masnari, Norma Ruppen-Greeff, Ana Vedes, 
Sabine Weber, and Helene Werner. A special thanks goes to Sabine Weber; sharing the office 
with her while writing this thesis provided me with immense scientific and emotional sup-
port.  
I am fortunate to be surrounded by great friends, most especially Thea Heck and Corina 
Hintermeister, who provided distraction and comfort. A great thanks also goes to my theatre 
ensemble Harri Olli; they helped me to change perspective with our exciting projects. 
My deepest gratitude goes to my family who provided me with encouragement and 
constantly supported me through all the time of my thesis; my parents Heinz and Rita Zeltner 
and my brothers Nico and Noah Zeltner. Finally, I am deeply thankful to Paul Baade, for his 
enormous support in all respects and for having been there for me throughout the past 3.5 
years. 
115   –    Curriculum Vitae    
 
Curriculum Vitae 
Nina Amélie Zeltner 
06.05.1986 
 
 
Education 
2015 – present   Universities of Basel, Bern, and Zürich 
    Post gradual education in psychotherapy for children and adolescents  
 
2013 – 2016  Children’s Hospital and Institute of Psychology, University of Zürich 
PhD studies, project: Development and evaluation of a quality of life ques-
tionnaire for children and adolescents with intoxication-type inborn errors of 
metabolism (Prof.Landolt, Prof. Bodenmann, Prof. Baumgartner) 
 
2013      University of Zürich  
       Master of Science in Psychology 
    Psychology (major), Biology (minor) 
       Health and Clinical Psychology  
Master thesis: Psychosocial Aspects in Endometriosis and Chronic Pelvic 
Pain (Prof. Ehlert) 
     
2010     University of Zürich 
    Bachelor of Science in Psychology  
    Psychology (major), Biology (minor) 
  
2008 – 2009   Université Paris Denis Diderot  
    Erasmus exchange year 
    Courses in Neurobiology und Chemistry 
 
  
Professional experience 
07 – 12/2011   Clienia Privatklinik Littenheid  
    Internship, department of psychotherapy for young adults 
    Based on cognitive behavioural therapy: DBT and schema therapy  
  
08 – 10/2009   University Children’s Hospital Zürich   
    Research internship in neurobiology (Prof. Stöckli) 
    fMRI-study: dyscalculia in children  
 
Curriculum Vitae   –    116 
 
06 – 08/2009   University of Zürich 
    Student research assistant for stress-studies (Prof. Ehlert) 
  
04/2006     Regional hospital Uster  
    Internship in nursing care 
 
08/2005 – 02/2006  Kindergarten and primary school Stadel  
    Assistant teacher  
 
 
Awards 
Poster prize for Poster presentation at the Children’s Research Centre Retreat (2015, October) enti-
tled Living with intoxication-type inborn errors of metabolism - a qualitative analysis of interviews with 
paediatric patients and their caregivers 
 
 
Publications 
Zeltner, N. A., Baumgartner, M. R., Ensenauer, R., Karall, D., Kölker, S., Mühlhausen, C., Scholl-
Bürgi, S., Thimm, E., Quitmann, J., Burgard, P., Landolt., M. A., Huemer, M. (in press). Development 
and psychometric evaluation of the MetabQoL 1.0 – a quality of life questionnaire for paediatric pa-
tients with intoxication-type inborn errors of metabolism. Journal of Inherited Metabolic Diseases Re-
ports. 
 
Zeltner N. A., Landolt M. A., Baumgartner M. R., Lageder, S., Quitmann, J., Sommer, R., Karall, D., 
Mühlhausen, C., Schlune, A., Scholl-Bürgi, S., Huemer, M. (2016). Living with intoxication-type inborn 
errors of metabolism - a qualitative analysis of interviews with paediatric patients and their parents. 
Journal of Inherited Metabolic Disease Reports, 31, 1-9. 
 
Zeltner, N. A., Huemer, M., Baumgartner, M. R., Landolt M. A. (2014). Quality of Life, Psychological 
Adjustment, and Adaptive Functioning of Patients with Intoxication-type Inborn Errors of Metabolism 
– a Systematic Review. Orphanet Journal of Rare Diseases, 9(1): 159.  
 
Zeltner, N. A., Ehlert, U., Heim, C. M., Wieser, F., Ditzen, B. (2013). Psychische Beschwerden im 
Rahmen gynäkologischer Erkrankungen am Beispiel der Endometriose. Verhaltenstherapie und Ver-
haltensmedizin, 34(4), 483-502.  
 
 
Presentations 
Zeltner, N. A., Landolt, M. A., Baumgartner, M. R., Huemer, M. (2016, November). Diät hält am Leben 
– Diät grenzt aus. Oral presentation at the FZK Symposium, Zürich, Switzerland. 
Zeltner, N. A., Landolt, M. A., Baumgartner, M. R., Ensenauer, R., Karall, D., Kölker, S., Mühlhausen, 
C., Scholl-Bürgi, S., Thimm, E., Quitmann, J., Burgard, P., Landolt., M. A., Huemer, M. (2016, Sep-
tember). Development and validation of a quality of life questionnaire for paediatric patients with in-
toxication-type inborn errors of metabolism. Poster presentation at the Society of the Study of Inborn 
Errors of Metabolism (SSIEM) Symposium, Rome, Italy. 
 
117   –    Curriculum Vitae    
 
Huemer, M., Zeltner, N. A. (2015, December). Lebensqualität bei Patienten mit angeborenen Stoff-
wechselkrankheiten. Workshop presentation at the Meeting of nutritionists “Update pädiatrische 
Diätetik”, Münster, Germany. 
 
Zeltner N. A., Landolt M. A., Baumgartner M. R., Lageder, S., Quitmann, J., Sommer, R., Mühlhausen, 
C., Schlune, A., Scholl-Bürgi, S., Karall, D., Huemer, M. (2015, October). Living with intoxication-type 
inborn errors of metabolism - a qualitative analysis of interviews with paediatric patients and their 
caregivers. Poster presentation at the Children’s Research Centre Retreat, Au, Switzerland. 
 
Zeltner N. A., Landolt M. A., Baumgartner M. R., Lageder, S., Quitmann, J., Sommer, R., Karall, D., 
Mühlhausen, C., Schlune, A., Scholl-Bürgi, S., Huemer, M. (2015, September). Health-related quality 
of life in children and adolescents with intoxication-type inborn errors of metabolism. Poster presen-
tation at the Society of the Study of Inborn Errors of Metabolism (SSIEM) Symposium, Lyon, France. 
 
Huemer, M., Zeltner, N. A., Bosch, A. (2015, June). Quality of life in patients with inborn errors of 
metabolism. Workshop presentation at the European Metabolic Group Meeting, Venice, Italy. 
 
Zeltner, N. A., Landolt, M.A., Baumgartner, M.R., Huemer, M. (2014, December). Lebensqualität bei 
Stoffwechselkrankheiten vom Vergiftungstyp. Oral presentation at the radiz Symposium, Zürich, 
Switzerland. 
 
Zeltner, N. A., Landolt, M. A., Baumgartner, M. R., Huemer, M. (2014, September). Health-related 
quality of life in children and adolescents with intoxication-type inborn errors of metabolism – patients’ 
and parents’ perspectives. Oral presentation at the Society of the Study of Inborn Errors of Metabo-
lism (SSIEM) Symposium, Innsbruck, Austria. 
 
Zeltner, N. A., Huemer, M., Baumgartner, M. R., Landolt M. A. (2014, May). Health-related quality of 
life in children and adolescents with inborn errors of metabolism – patients’ and caregivers’ perspec-
tives. Oral presentation at the European Metabolic Group Conference, Zürich, Switzerland.  
 
Zeltner, N. A., Huemer, M., Baumgartner, M. R., Landolt M. A. (2014, January). Quality of life of 
patients with intoxication-type inborn errors of metabolism – a neglected field of research? Oral 
presentation at the Austrian-Swiss Metabolic Meeting, Zürich, Switzerland. 
Zeltner, N. A., Huemer, M., Baumgartner, M. R., Landolt M. A. (2013, September). Health-related 
Quality of Life and Psychological Adjustment in Patients with Intoxication-type Inborn Errors of Me-
tabolism: Preliminary Results of a Systematic Review. Poster presentation at the 12th International 
Congress of Inborn Errors of Metabolism, Barcelona, Spain.  
 
Zeltner, N. A., Baumgartner, M. R., Huemer, M., Landolt M. A. (2013, July). Measuring Health-related 
Quality of Life in Children with Intoxication-type Inborn Errors of Metabolism. Poster presentation at 
the 1st Rare Disease Summer School, Zürich, Switzerland. 
